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Chlamydia trachomatis infections in the female genital tract can cause damaging inflammation 
and scarring that leads to ectopic pregnancy and/or infertility. Using the mouse model of genital 
chlamydial infection with Chlamydia muridarum, it is evident that damage to the reproductive tract is 
strongly associated with neutrophils, while a CD4 T cell response is required to clear infection. These 
topics on chlamydial pathogenesis will be introduced in Chapter 1. In Chapter 2, I present novel data on 
the contribution of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1), an activation receptor 
on neutrophils, during genital C. muridarum infection in female mice. We show that TREM-1 promotes 
neutrophil-induced tissue damage in uteri, and neutrophils lacking TREM-1 undergo reduced 
transepithelial migration into the uterine lumens. 
While mouse models have greatly improved our understanding of the host immune responses to 
Chlamydia infection, translating the findings to humans require studies in primary cells of human origin. 
Intracellular chlamydiae are eliminated in both mouse and human epithelial cells by IFNg secreted from 
immune cells, but via independent downstream intracellular mechanisms to eliminate chlamydiae. 
Further, C. trachomatis and C. muridarum have evolved unique defenses against these host-specific 
responses. To address this unmet need, In Chapter 3, I will describe a primary human Fallopian tube 
epithelial cell (FTE) model to study C. trachomatis-host cell interactions. These cells polarize, ciliate, and 
secret mucus, like Fallopian tube explants. The cells respond to C. trachomatis infection by increasing 
production of amino acid transporters, immune cell chemoattractants, and increasing cell surface 




to C. trachomatis infection as a result of high basal expression of IFNg-inducible IDO1, an enzyme that 
depletes host cellular tryptophan Chlamydia requires for growth and replication. 
Overall, the findings from this thesis provide novel insight on the contribution of a novel 
neutrophil activation receptor on uterine pathology and discovery of an innate mechanism in human FTE 
cells, which reduces chlamydial infection. These findings have significant translational potential to 
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CHAPTER 1 : INTRODUCTION 
SUMMARY 
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the world. 
An estimated 700,000 cases were reported in the United States in 2000 alone. Over 1.8 million cases were 
reported in the U.S. in 2019, with 1.1 million of them in women (1). Genital chlamydial infections are 
often asymptomatic, leading to many undiagnosed cases. Therefore, the actual number of cases in the 
United States likely exceeds 3 million. Although infections in females are initiated at the endocervix, 
without antibiotic treatment, infection can ascend and promote inflammation in the uterus (endometritis) 
and/or Fallopian tubes (salpingitis). Consequently, the inflammation of these two organs can lead to the 
clinical syndrome of pelvic inflammatory disease (PID), which occurs in roughly 10% of infected women 
(2, 3). Symptoms of PID include lower abdominal and pelvic pain with cervical and adnexal tenderness 
upon palpation. Inflammation in the upper genital tract can lead to irreversible scarring that can cause 
infertility or potentially life-threatening ectopic pregnancy (4-6). Subclinical endometritis or “silent PID” 
has also been documented by biopsy and is associated with a 40% decline in fertility (7). Although 
chlamydial infections in men and women are routinely cleared with antibiotic therapy, damage to 
women’s Fallopian tubes can be irreversible. Therefore, research should focus on increasing our 
understanding of the pathogenesis of chlamydial infection to enhance methods to prevent these 
reproductive sequelae. 
The advancement of in vitro cell culture and mouse models have significantly improved our 
understanding of genital chlamydial infections. Immortalized cells lines, such as the cervical lines HeLa 
and A2EN, and the oviduct epithelial (OE) cell line, provide excellent tools to study Chlamydia-host cell 




examination of responses from supportive tissue cells or systemic immune cells that traffic to infected 
tissues. Further, transformed cells have the potential for reduced inflammatory responses to chlamydial 
infections compared to primary cells (8-10). Mice provide a cost-effective, easily-housed animal model 
with ample reagent availability. Chlamydia muridarum, formerly called C. trachomatis Mouse 
Pneumonitis agent (MoPn) strain, is native to the mouse and was originally isolated from mouse lungs 
(11). It has been adapted to cause genital tract infection by inoculating it into the female mouse vagina, 
where it infects the endocervix and ascends to the uterine horns and oviducts, inducing inflammation and 
tissue damage as observed in humans (12-15). Mouse models have provided a significant contribution to 
our understanding of the chlamydial genes that promote ascension and disease, and the host innate and 
adaptive immune responses to infection that correlate with tissue damage and protection (reviewed in (16-
18)). However, studying the chlamydiae-host interactions in mouse cells with C. muridarum can be 
challenging to relate to humans. Chlamydia trachomatis and C. muridarum have both evolved to survive 
in their respective host. Specifically, the host intracellular growth-restriction mechanisms for chlamydiae 
in mice and humans, as well as the responses to them between C. muridarum and C. trachomatis, differ 
(19-21). Therefore, data generated from both of these model systems of must be carefully interpreted with 
respect to native human infections.  
In this dissertation, Chapter 1 will serve as an overall introduction to the field, the chlamydial 
developmental cycle in host epithelial cells, followed by the epithelial response and the contribution of 
the first responder immune cells, neutrophils in the development of disease. To conclude Chapter 1, I will 
address the intracellular defense mechanisms to chlamydiae in epithelial cells and how immune cells 
assist in eliminating intracellular infection. In Chapter 2, I will expand on the neutrophil response and its 
role in host pathology during chlamydial infection. Specifically, I will describe the contribution of an 
activation receptor, Triggering Receptor Expressed on Myeloid cells 1 (TREM-1), which is highly 
expressed on neutrophils, in chlamydial pathogenesis using the mouse model. In Chapter 3, I will 




host epithelial responses. It has been previously reported that indoleamine 2,3-dioxygenase (IDO)-
mediated inhibition of C. trachomatis is driven by g-interferon (IFNg) produced from immune cells (22, 
23). We discovered FTE cells have constitutively high IDO expression that inhibits chlamydial infection 
in the absence of immune cells. Finally, in Chapter 4, I will discuss the overall implications of our 
findings and the impact this work has on chlamydial pathogenesis research.  
CHLAMYDIAL DEVELOPMENTAL CYCLE  
Chlamydia spp. are Gram-negative obligate intracellular bacteria with a unique biphasic 
developmental cycle (summarized in (Fig 1.1)). They contain a 7.5 kb plasmid that has been previously 
shown to act as a transcriptional regulator and encodes several virulence factors. Although the plasmid in 
not required for chlamydial growth, the functions of all the plasmid-encoded genes are not fully known 
(24, 25). Infection begins when the infectious Chlamydia form, the elementary body (EB), binds to 
receptors on the surface of epithelial cells. First, low-affinity binding of chlamydial OmcB to heparan 
sulfate proteoglycans on the host cell surface occurs (26), followed by high-affinity binding of chlamydial 
lipids and proteins to various host cell receptors. These include binding of chlamydial LPS to the host cell 
cystic fibrosis transmembrane conductance regulator (CTFR), chlamydial MOMP to the host mannose 6-
phosphate receptor, Ctad1 to host b1 integrin, and/or Pmp21 to host epidermal growth factor receptor 
(EGFR) (27-30). Bound chlamydial EBs inject pre-synthesized effectors through a type III secretion 
system, which promotes actin remodeling to initiate host cell plasma membrane invagination and EB 
internalization and prevent lysosome fusion (reviewed in (31)). Upon actin remodeling, chlamydiae are 
endocytosed, stealing part of the host cell membrane to encase the chlamydiae inside of a vacuole, termed 
an inclusion. At this point, EBs convert to the replicative form, termed a reticulate body (RB). Reticulate 
bodies increase their metabolism and begin making proteins necessary for nutrient acquisition. One set of 
proteins, called inclusion membrane (Inc) proteins, are synthesized and localize to the surface of the 
inclusion. There are well over thirty identified Inc proteins found in C. trachomatis, and many more may 




unknown (reviewed in (33). One important function is to bind to host cell microtubules and traffic the 
inclusion to the nutrient-rich microtubule-organizing center, where multiple inclusions meet and fuse 
together (34). Organization of microtubules around the inclusion also provide structural integrity to the 
inclusion (35). Several Inc proteins recruit host vesicle associated membrane proteins that prevent 
lysosome fusion (reviewed in (36)). Additionally, it is likely Inc proteins are responsible for the 
recruitment of host RAB-GTPases to the inclusion, where they aid in lipid and nutrient acquisition from 
the Golgi apparatus (reviewed in (37)).  
Chlamydiae utilize many host cell proteins and nutrients for their development. Multiple host 
proteins have been found in the membranes of chlamydiae (reviewed in (38)). Chlamydiae are able to 
scavenge degraded proteins from host lysosomes as one source of amino acids (39). Tryptophan, an 
essential amino acid for the host and chlamydiae, contributes to the replication of certain species of 
Chlamydia, including C. trachomatis. When low levels of tryptophan are present inside an infected host 
cell, C. trachomatis responds by producing tryptophan synthase, which can convert the bacterial waste 
product indole, potentially available from other bacteria, into tryptophan (40). If there is insufficient 
tryptophan, or indole available to synthesize tryptophan, chlamydiae will either die or enter a non-
replicating state, identified as aberrant bodies (41, 42). Once tryptophan levels become sufficient inside 
the cell, aberrant bodies will revert back to RBs and resume replication. After substantial replication, RBs 
will convert into EBs and prepare for release from their host cell to infect new cells.  
Although the signals that promote chlamydial release from a cell are not well understood, two 
main mechanisms of chlamydial release have been described – cell lysis and inclusion extrusion (43). Cell 
lysis results in release of free chlamydiae, chlamydial components and inclusion contents, and host 
intracellular components that can activate an immune response in neighboring uninfected epithelial cells, 
and tissue resident or infiltrating systemic immune cells. Extrusion release is a slow process in which 
chlamydiae are released in a membrane-encased compartment. Chlamydial extrusions have been 




immune dampening cytokine IL-10, which increases expression of the T cell suppressive ligand PD-L1, 
and enhances apoptosis of dendritic cells (44). 
INNATE RESPONSES TO INFECTION  
 In the genital tract, chlamydiae primarily infect epithelial cells. Despite Chlamydia’s best 
attempts to hide from the immune response, host epithelial cells successfully detect infection and initiate 
an immune response. Chlamydiae have previously been shown to activate multiple pathogen recognition 
receptors. Stimulation of Toll-like receptor 2 (TLR2) leads to NF-kB activation and the release of 
chemokines and pro-inflammatory cytokines that drive recruitment and activation of immune cells (45, 
46). Although bacterial TLR2 ligands, such as peptidoglycan and lipoproteins, are well described, the 
chlamydial component that stimulates TLR2 remains undefined (47-49). However, mice deficient in 
TLR2 had reduced genital tract pathology, suggesting an important role for this receptor during 
chlamydial infection (45). Chlamydial LPS weakly stimulates TLR4 in vitro (50) and little role has been 
shown for TLR4 in development of genital tract pathology during chlamydial infection (45). Other TLRs, 
such as TLR7 and TLR9 that recognize ssRNA and CpG DNA, respectively, also seem to have little role 
in responding to chlamydial infection (51). It remains unclear whether TLR3, which detects dsRNA, is 
activated during chlamydial infection. One previous study showed an indirect mechanism by which TLR3 
recognized RNA from damaged infected cells (52). Cytoplasmic DNA can be sensed by cGAS during 
chlamydial infection, which leads to Stimulator of Interferon Genes (STING) activation  and type I 
interferon production (53, 54). There are two types of NOD-like receptors (NLRs), NLRC and NLRP, 
located in the cytosol that are activated during chlamydial infection and can trigger caspase-1 activation 
and lead to inflammasome activation that promotes interleukin (IL)-18 and IL-1b release and cell death 
(reviewed in (55)). Specifically, Chlamydia activates NLRP3 to induce inflammasome activation (56-58). 
Activation of any of these sensors initiates a robust inflammatory response through NF-kB signaling, 
mitogen-activated protein kinase (MAPK), and/or interferon regulatory factor 3 (IRF3) activation. 




(TNFa), interferon-b (IFNb), granulocyte-macrophage colony-stimulating factor (GM-CSF), and the 
chemokines (C-X-C motif) CXCL1 and CXCL10 to recruit and activate innate and adaptive immune cells 
(59-61). 
NEUTROPHIL RESPONSE AND TISSUE DAMAGE. 
During many bacterial infections, neutrophils are a front-line defense recruited towards 
chemokine gradients released by infected tissue cells. At the site of infection, neutrophils eliminate 
pathogens by phagocytosis and release of granule contents containing proteases, lysozymes, and reactive 
oxygen species (ROS) (reviewed in (62)). During chlamydial infection in mice, neutrophils are also the 
first to arrive at the infection site, as early as 12 h after infection (63). Although neutrophils are able to 
reduce infectious load early in infection (63), they are ineffective in clearing infection. Conversely, there 
are several lines of evidence to suggest that neutrophils are damaging to the host. For instance, mice 
infected with plasmid-cured chlamydiae fail to develop pathology and have reduced neutrophil infiltration 
to their oviduct (64). Likewise, mice lacking IL-1R or IL-1a are protected from pathology and have 
reduced neutrophil infiltration to the oviduct (65). Mice lacking matrix metalloprotease-9 (MMP-9), a 
protease secreted by neutrophils that breaks down the extracellular matrix, are protected from oviduct 
pathology suggesting that release of MMP-9 from neutrophils promotes damage to the genital tract (66). 
Further, chlamydiae have evolved mechanisms to cripple neutrophils by preventing their degranulation, 
NET formation, and ROS production, greatly inhibiting their ability to kill extracellular infectious EBs. 
Chlamydial Protease-like Activity Factor (CPAF) is made by chlamydiae and released into the 
environment when the cell lyses. CPAF cleaves formyl peptide receptor 2 (FPR2) on the surface of 
neutrophils, which prevents FPR2 from activating neutrophil migration, degranulation, and ROS 
production (67, 68). Despite CPAF-mediated inhibition of their killing capacity, sufficient neutrophil 
activation and degranulation occurs to result in collateral tissue damage, through release of ROS and 
MMP-9 (66, 69-73). Thus, CPAF likely only paralyzes neutrophils that come into close proximity of 




PID reveal neutrophil infiltrates (74). Given the importance of neutrophils in tissue damage associated 
with chlamydial infection, we sought to determine signals that promote neutrophil activation in the genital 
tract during infection.  
There are multiple activating signals on neutrophils, such as TLRs, FcgRs, GPCRs, and cytokine 
receptors. However, our lab previously showed the signaling pathway of an activation receptor, Trigger 
Receptors Expressed on Myeloid Cells - 1 (TREM-1), was the top upregulated mRNA pathway in the 
whole blood of women with C. trachomatis-induced endometritis (75). There are four TREMs, TREM 1-
4, and their role is to modulate immune cell recruitment and activation. TREM-1 is a transmembrane 
receptor with an Ig-like domain. The cytoplasmic tail associates with DNAX-activating protein of 12 kDa 
(DAP12) to initiate downstream signaling (76). Src family kinases phosphorylate DAP12 which results in 
downstream activation of NF-kB (77, 78). TREM-1 increases calcium influx that promotes neutrophil 
degranulation and production of ROS, chemokines, and cytokines (76, 79, 80). Activation of TREM-1 
can induce neutrophil activation alone or in synergy with TLRs (76, 81). Deletion of TREM-1 has been 
shown in other intracellular infection models to alleviate immune associated pathologies caused by 
neutrophils while not compromising the host’s ability to clear infection through adaptive responses (82, 
83). Conversely, mice infected with pathogens that require a neutrophilic response to clear infection had 
increased pathogen load and worse disease progression (84, 85). Together, these data suggest an 
important role for TREM-1 activation on neutrophils during pathogenic infections. TREM-2 does not 
result in NF-kB activation and has been previously shown to promote anti-inflammatory effects (86-88). 
TREM-3 is present in mice, but is a pseudogene in humans. It initiates the same proinflammatory effects 
as TREM-1 through association with DAP12 (89). TREM-4 is found in capillary endothelium, cardiac 
tissue, and testes and assists in lymphocyte adhesion (90, 91).  
Although TREM-1 is the most well described of these receptors, a definitive ligand has remained 
elusive. However, several studies have demonstrated binding of several proteins, such as CD177, 




innate immune response. Another study showed TREM-1 binding to platelets and that the neutrophil 
LPS-induced respiratory burst was enhanced in the presence of platelets (96). These studies suggest that 
TREM-1 does not have a single ligand, but instead can amplify neutrophil activation in a variety of 
situations. Therefore, it is possible more unidentified ligands exist. In Chapter 2, I will discuss data that 
reveal a role for TREM-1 in neutrophil-induced uterine pathology in the mouse genital tract during 
Chlamydia infection. 
DEFENSES AGAINST CHLAMYDIA 
Gamma interferon is a primary cytokine associated with defense against chlamydial infection. 
The primary source of IFNg early during infection is natural killer (NK) cells, which are one of the first 
immune cell types to be recruited to the site of infection. NK cells also recruit CD4 T cells that assist in 
clearing infection by secreting additional IFNg (97, 98). Activation of IL-1 receptor (IL-1R) on epithelial 
cells by IL-1a or IL-1b also increases expression of g-interferon receptor (IFNGR) on the cell surface 
(99). In humans, activation of IFNGR on epithelial cells from IFNg triggers the upregulation of 
intracellular indoleamine 2,3 dioxygenase (IDO), which catabolizes tryptophan, depleting it in the cell 
(100) and ultimately starving Chlamydia of this essential amino acid (Fig. 1.2). This is the primary innate 
immune mechanism for chlamydial clearance in humans. In the presence of indole, C. trachomatis can 
produce tryptophan using the enzyme tryptophan synthase to overcome tryptophan depletion. Chlamydia 
muridarum lacks expression of tryptophan synthase, and therefore cannot use indole to synthesize 
tryptophan, making it sensitive to human IFNg mediated IDO expression (21), Conversely, IFNg in mouse 
cells do not induce IDO expression, but instead make p47GTPase that can target C. trachomatis but not 
C. muridarum. Therefore, host cell tropism is an important variable to be considered while modeling 
human disease with a mouse pathogen. Towards this, in Chapter 3, I will describe the generation of an in 
vitro primary human FTE cell model. Using this model, we show that constitutive IDO production by 






Figure 1.1: The Chlamydia life cycle.  
Chlamydial elementary bodies (EBs) (small red dots) bind to the surface of uninfected epithelial cells 
using a variety of receptors. Upon internalization, EBs will convert into replicating reticulate bodies 
(medium red dots), where they will replicate and increase inclusion size. With the introduction of stress, 
such as IFNg treatment that depletes tryptophan, penicillin, or nutrient limitation, RBs will stall 
replication in the form of aberrant bodies (large red dots). After the stress is removed, replication can 
continue. After substantial replication, newly synthesized RBs will convert into EB and exit the cell 






Figure 1.2: IDO pathway in Chlamydia-infected cells.  
Chlamydiae can be detected by multiple sensors, such as TLRs and cGAS. Consequently, NF-kB 
activation occurs, upregulating expression of IL-1 and IFNGR, and chemokines that attract immune cells. 
As NK and T cells are recruited to infected cells, they release IFNg that binds to IFNGR. This results in 
STAT1 activation and an increase in IDO, which converts tryptophan to kynurenine, depleting the cells of 
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CHAPTER 2 : REDUCED UTERINE TISSUE DAMAGE DURING CHLAMYDIA 
MURIDARUM INFECTION IN TREM-1,3 DEFICIENT MICE13 
SUMMARY 
Genital infections with Chlamydia trachomatis can lead to uterine and oviduct tissue damage in 
the female reproductive tract. Neutrophils are strongly associated with tissue damage during chlamydial 
infection, while an adaptive CD4 T cell response is necessary to combat infection. Activation of 
triggering receptor expressed on myeloid cells-1 (TREM-1) on neutrophils has previously been shown to 
induce and/or enhance degranulation synergistically with TLR-signaling. Additionally, TREM-1 can 
promote neutrophil transepithelial migration. In this study, we sought to determine the contribution of 
TREM-1,3 in immunopathology in the female mouse genital tract during Chlamydia muridarum 
infection. Relative to control mice, trem1,3-/- mice had no difference in chlamydial burden or duration of 
lower genital tract infection. We also observed a similar incidence of oviduct hydrosalpinx 45 days post-
infection in trem1,3-/- compared to WT mice. However, compared to WT,  trem1,3-/- mice developed 
significantly fewer uterine horn hydrometra. Early in infection, trem1,3-/- mice displayed a notable 
decrease in the number of uterine glands containing polymorphonuclear cells and uterine horn lumens had 
fewer neutrophils, with increased G-CSF. Trem1,3-/- mice also had reduced erosion of the luminal 
epithelium. These data indicate TREM-1,3 contributes to transepithelial neutrophil migration in the uterus 
and uterine glands, promoting the development of uterine hydrometra in infected mice. 
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The most common sexually transmitted bacterial infection in women is caused by Chlamydia 
trachomatis (1). Infection is often asymptomatic and goes undetected, leading to ongoing inflammation 
that causes pelvic inflammatory disease with sequalae such as chronic pelvic pain, ectopic pregnancy, 
and/or infertility (2-4). Excessive neutrophil recruitment in the upper genital tract during chlamydial 
infection contributes to long-term damage (5-7). It is well established that in mucosal tissues, neutrophils 
can promote epithelial damage and disrupt barrier function when they cross from the basal side of the 
epithelium into the lumen (6, 8-11). Therefore, identification of the precise mechanisms that induce 
neutrophil recruitment, transepithelial migration (TeM), and activation in the genital mucosa could reveal 
potential therapeutic targets to alleviate sequalae during chlamydial infections.  
Neutrophils express G-protein-coupled, Fc, adhesion, cytokine, and pattern recognition receptors 
on their surface, which are activated during pathogenic infections (reviewed in (12)). However, the 
combination of activation signals that contribute to neutrophil-mediated tissue damage during chlamydial 
infection in the genital tract remain unclear. A recently described set of receptors, known as triggering 
receptors expressed on myeloid cells (TREM) has been discovered to modulate myeloid cell activation. 
TREM-1 is found primarily on monocytes and neutrophils and can independently activate these cells or 
synergize with toll-like receptor activation (13-15). TREM-1 is an Ig-like receptor that associates with 
DNAX activation protein of 12 (DAP-12) to initiate downstream activation of PI3K and ERK (16). There 
are multiple reports of potential ligands for TREM-1 (17-19), which can bind to TREM-1 and result in 
NF-kB and NFAT activation, causing proinflammatory cytokine/chemokine release, production of 
reactive oxygen species (ROS), and degranulation (reviewed in (20)). Studies using the intracellular 
pathogens Leishmania major, influenza, and lymphocytic choriomeningitis virus (LCMV) have 
demonstrated TREM-1 deficiency results in reduced disease, thus improving overall outcome (21, 22). 
Conversely, during extracellular pathogenic infections such as Klebsiella pneumoniae and Pseudomonas 




24), likely as a result of an impaired innate immune response. In an E. coli sepsis model, TREM-1 
blockade increased mouse survival by reducing the host’s systemic proinflammatory response (14). 
TREM-1,3 expression also contributed to neutrophil TeM in the murine lung during P. aeruginosa 
infection (24). Together these findings demonstrate an important role for TREM-1,3 on neutrophil 
proinflammatory activation and TeM during pathogenic infections.  
Our lab recently discovered the TREM-1 signaling pathway was one of the top ten gene 
transcriptional pathways upregulated in the whole blood of C. trachomatis-infected women with 
endometritis (25). To address the hypothesis that TREM-1 contributes to genital tract pathology during 
chlamydial infection, we infected mice deficient for TREM-1,3 (trem1,3-/-) with C. muridarum in the 
genital tract and determined infection course, immune cell recruitment, and end-point pathology in uterine 
horns and oviducts. We show that TREM-1 is exclusively expressed on myeloid cells in the genital tract 
of infected mice, and loss of TREM-1,3 reduces uterine horn pathology, but not oviduct pathology. 
TREM-1,3 were not essential for clearing chlamydial infection, as infection burden and course in trem1,3-
/- mice mirrored WT mice. Though there was no reduction in the incidence of oviduct hydrosalpinx at day 
45 post-infection, trem1,3-/- mice had a significantly reduced incidence of uterine hydrometra. At 7 days 
post-infection, we observed that trem1,3-/- mice had a reduced number of uterine glands containing 
polymorphonuclear cells (PMNs), and reduced neutrophil transmigration into the uterine horn 
accompanied with increased levels of G-CSF. We also observed reduced epithelial erosion 21 days post-
infection in trem1,3-/- mice. Together, our data indicate a contributory role for TREM-1,3 in neutrophil 







MATERIALS AND METHODS 
Mice 
Age-matched wild type C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor, 
ME, 000664) and acclimated to the UNC-CH animal facility for at least 7 days prior to experiments. For 
this study, we obtained mice deficient in trem1 and trem3 from Dr. Julia Klesney-Tait at the University of 
Iowa Carver College of Medicine (24). Genetic deletion of trem1,3 was confirmed by genomic PCR with 
primers TCTCTCCATCTATGCATCCACCC (F1), TCCCAAGAGCAGGCACAAGA (F2), and 
TCTTGCCGCTGATTGGTTCA (R) as previously described (24). All mice were housed at the UNC-CH 
animal facility in a pathogen-free environment and studies were approved by the Institutional IACUC 
committees. 
Chlamydia muridarum infection 
Chlamydia muridarum strain “Nigg” stocks were propagated and titrated in L929 monolayers as 
previously described (26). Stocks were stored in sucrose-sodium phosphate-glutamic acid (SPG) buffer at 
80°C until use. 8–10-week-old mice were administered 2.5 mg Depo-Provera (medroxy-progesterone 
acetate (Upjohn)) in 100 µl sterile PBS subcutaneously 7-10 days prior to infection to induce anestrous. 
Mice were anesthetized intraperitoneally with 10µl/gram weight of sodium pentobarbital (5 mg/ml) in 
sterile PBS and infected intravaginally with 3 x 105 IFUs in 20µl SPG buffer. At the indicated time 
points, chlamydial shedding was assayed by cervico-vaginal swabs of each mouse and rotating swab 10 
times. Swabs were collected in 1 mL SPG buffer and DNA was extracted using Quick-DNA Miniprep kit 
(Zymo D3024). The amount of chlamydial DNA in extracts was quantified by qPCR using primers 
against ompA (MOMP) as previously described (27). 
Flow cytometry  
Uterine horns were excised from mice post mortem and processed for flow cytometry analysis. 




hundred µl of HBSS (-Ca, -Mg) with 5% FBS was carefully pipetted through each uterine horn with a 200 
µl pipet tip and collected. The remaining tissue and non-lavaged uterine horns were processed as 
previously described (28). Briefly, single-cells suspensions of tissues were obtained by mincing of tissue 
and digestion with collagenase for 60 minutes at 37°C. Digested tissue were filtered through a 70 µm 
followed by a 40 µm filter to obtain single-cell suspensions. Cells were stained with Zombie UV 
live/dead stain (Biolegend 423107) diluted 1:500 in PBS. Cells were washed with cell stain buffer 
(Biolegend 420201) and resuspend in Fc block (BD 553142). Cells were stained using the following 
antibodies with conjugated fluorophores: anti-CD45 – PerCP-Cy5.5 (BD clone 30-F11), anti-CD11b – 
APC (Biolegend clone M1/70), anti-Ly6G – FITC (Biolegend clone IA8), anti-Ly6C – BV605 
(Biolegend clone HK1.4), anti-F4/80 – PE-Dazzle (Biolegend clone BM8), anti-TREM-1 – PE (R&D 
FAB1187P), anti-CD3 – APC/Cy7 (Biolegend clone 17A2), and/or anti-CD8a – PE/Cy7 (Biolegend 
clone 53-6.7). Gating for immune cells was performed as previously described using appropriate FMOs 
(28). Cells were washed 3 times in cell stain buffer and fixed in 2% formaldehyde. Cells were analyzed 
on LSR II (BD) at the UNC Flow Cytometry Core and data analyzed using Cytobank (29).  
Cytokine expression 
After preparation of single cell suspension for flow cytometry, 1/20 of each cell suspension was 
isolated and diluted 1:2. After a freeze thaw cycle to lyse cells, supernatants were collected and total 
protein was quantified using BCA assay kit (Pierce 23225). Supernatants were assayed for cytokines 
using Milliplex MAP Mouse cytokine/chemokine magnetic bead panel (Millipore MCYTOMAG-70K) 
containing beads with antibodies against mouse G-CSF, IL-1b, CXCL1 (KC), CXCL2 (MIP-2), CCL2 
(MCP-1), and TNFa following manufacture’s protocol. Analysis was performed using a Bio-Rad 
MAGPIX multiplate reader with Bio-Plex Manager MP software (BioRad). Cytokine concentrations were 
normalized to total protein levels in each sample. Samples that fell below the level of detection were 





Genital tracts of mice were removed post-mortem and place in 10% formalin in PBS for 24 hours. 
Tissues were rinsed with PBS for 24 hours and embedded in paraffin. Sections of the genital tract were 
cut longitudinally 4µm thick and stained with hematoxylin and eosin (H&E). Method for counting uterine 
hydrometra was followed as previously described (30). Histological scoring was performed using a semi-
quantitative 4 tier rating system previously described (31). The endocervix, uterine horns, oviducts, and 
mesosalpinx were evaluated for polymorphonuclear cells (PMNs), mononuclear cells, plasma cells, 
dilatation, chronic inflammation, and fibrosis. To detect neutrophils, paraffin-embedded sections were 
deparaffinized and rehydrated using a series of graded alcohols. Heat-induced epitope retrieval was 
performed using pH 6.0 buffer (Thermo TA-135-HBL), after which endogenous peroxidase activity was 
quenched with 3% hydrogen peroxide. Sections were blocked in 10% normal goat serum for one hour, 
then incubated overnight at 4°C with rat anti-Neutrophil antibody (Abcam AB2557) diluted 1:100. 
Sections were then incubated in biotinylated goat anti-rat IgG (Jackson 112-065-167) diluted 1:500 for 
one hour at room temperature. Signal was amplified with a Vectastain Elite ABC-HRP kit (Vector 
Laboratories, PK-6100), per the manufacturer’s instructions and detected using a DAB chromogen 
(Thermo, TA-125-QHDX). Finally, sections were counterstained with Hematoxylin (Thermo 6765003), 
dehydrated with a series of graded ethanols, cleared with xylene, and cover-slipped with DPX Mounting 
Medium (EMS, 13512). 
Statistical analysis 
For chlamydial shedding data from multiple time points, experiment was performed two times. 
All statistical analysis was performed using GraphPad’s Prism 9.0 software. Statistical significance was 
determined using two-way ANOVA with Šídák’s multiple comparison. Statistical significance for 
hydrometra incidence was determined using t test with Welch’s correction. Statistical analysis for 




measured by flow cytometry, were determined for each cell type and each cell type was calculated as a 
percentage of the total live cell population. Statistical analysis performed on cell type quantification was 
preformed using Two-Way ANOVA with Šídák's multiple comparisons test. For histological scoring, 
statistically significance was determined using nonparametric Mann-Whitney test. N values were for each 
experiment are included in figure legends. 
RESULTS 
TREM-1 is predominantly expressed on neutrophils in the female mouse genital tract during 
chlamydial infection. TREM-1 is expressed at high levels on monocytes and neutrophils, but it is also 
expressed at low levels on T cells and mucosal lung epithelial cells (reviewed in (32)). To determine the 
cell types that express TREM-1 in the mouse female genital tract during infection, we infected mice with 
C. muridarum, excised the uterine horns 7 days post-infection to generate single cell suspensions and 
determined surface expression of TREM-1 on multiple cell types by flow cytometry. TREM-1 was not 
detected on cells that did not express the leukocyte marker CD45, which includes stromal and epithelial 
cells. In CD45+ cells, TREM-1 was not expressed on non-myeloid cells (CD11b-), but was detected on 
one-third of myeloid cells (CD11b+). While a small percentage of monocytes (CD11b+, Ly6C+, Ly6G-) 
expressed TREM-1, the majority of neutrophils (CD11b+, Ly6C+, Ly6G+) expressed TREM-1 (Fig. 
2.1A). As expected, myeloid cells from trem1,3-/- mice lacked TREM-1 surface expression (Fig. 2.1B).  
TREM-1,3 contributes to pathology in the uterine horns but not the oviducts. TREM-1 activation 
of neutrophils leads to ROS production and degranulation (33, 34), which can impact chlamydial growth 
and tissue pathology. To determine the contribution of TREM-1 in chlamydial pathogenesis, we used a 
mouse strain in which trem3 was deleted with trem1 (24). Trem3 is a pseudogene in humans, shares high 
sequence homology with trem-1, and lies adjacent to trem-1 on the genome (35). Further, both TREM-1 
and TREM-3 activate shared signaling pathways (35, 36), suggesting overlapping functions. As such, 




infected with C. muridarum and cervico-vaginal swabs were obtained at intervals over 45 days and 
assessed for chlamydial DNA by qPCR. We observed no difference in chlamydial burden or infection 
kinetics over a 45-day period in the trem1,3-/- mice compared to WT mice (Fig. 2.2A). At 45 days post-
infection, mice were sacrificed and genital tracts were assessed for gross pathology. Mice deficient in 
TREM-1,3 had a similar incidence of oviduct hydrosalpinx compared to wild-type mice (Fig. 2.2B, C). 
Chlamydial infection commonly results in cystic dilatation in the uteri of mice in which glands are 
swollen and filled with fluid (30, 37, 38), termed hydrometra. Although trem1,3-/- mice had similar 
numbers of oviduct hydrosalpinx as WT mice, they developed significantly fewer hydrometra in their 
uteri (Fig. 2.2B, C). Therefore, TREM-1,3 signaling contributes to uterine pathology during infection. 
TREM-1,3 contributes to neutrophil transepithelial migration. To investigate the possible 
contributing factors that led to hydrometra formation, we assessed histological sections from 7 days-post 
infection. We found the presence of PMNs in the uterine horn glands in WT mice, which was less 
frequent in trem1,3-/- mice. (Fig. 2.3). However, we were unable to accurately quantify glandular size and 
number of PMNs present due to limitations of single plane histological sectioning. Therefore, we sought 
to determine if TREM-1,3 deficiency altered neutrophil infiltration during Chlamydia infection in the 
uterine horns. We observed similar bacterial loads and frequencies of immune cell infiltrates, including 
monocytes and neutrophils, in single cell suspensions of whole uterine horn tissues at 7 days post-
infection (Fig. 2.4A, B). Immunohistochemical staining for neutrophils revealed prominent infiltrates in 
the lumens of both WT and trem1,3-/- mice 7 days post-infection. However, increased densities of 
neutrophils were observed at the basal surface of the uterine horn luminal epithelium in trem1,3-/- mice 
compared to WT mice (Fig. 2.5A), suggesting a reduction in neutrophil TeM in the absence of TREM-
1,3. Indeed, histological scoring at 7- and 21-days post-infection in the uterine lumen of trem1,3-/- mice 
revealed a reduced presence of PMNs (Fig. 2.5B). To calculate the percentage of total neutrophils that 
had migrated into the lumen, we collected uterine horn lavages and prepared cell suspensions from uterine 




contained large numbers of neutrophils. However, the fraction of total tissue neutrophils (Ly6C+, Ly6G+) 
that migrated to the lumen was reduced in trem1,3-/- mice compared to WT (Fig. 2.5C), revealing TREM-
1,3’s contribution to neutrophil TeM in infected uteri. We found no difference in the fractions of total 
tissue monocytes (Ly6C+, Ly6G-) in uterine lumens between trem1,3-/- and WT mice (data not shown). 
Interestingly, despite similar neutrophil recruitment to the uterine horns between WT and trem1,3-/- mice, 
and a reduced infiltration of neutrophils in the lumen of trem1,3-/- mice, at 7 days post-infection we 
observed increased G-CSF protein in whole uterine tissue homogenates (Fig. 2.5D). However, we 
observed no difference in CXCL1 (KC) or CXCL2 (MIP-2) proteins in the uterine horn homogenates 
between WT and trem1,3-/- mice (Fig. 2.4C), while IL-1b, TNFa, and CCL2 (MCP-1) levels were below 
the level of detection in WT and trem1,3-/- mice (data not shown). Together, our data indicate an 
association between reduced hydrometra and glandular PMN infiltration, that could be the result of 
reduced PMN TeM. 
Trem1,3-/- mice have reduced epithelial erosions in the uterine horns. Neutrophils in the lumen 
can cause damage to epithelial barriers by releasing toxic granules (39). To determine if the defect in 
neutrophil TeM would impact epithelial erosion, WT and trem1,3-/- mice were evaluated for epithelial 
erosion by histological scoring at 7-, 21-, and 45-days post-infection. Mice deficient for TREM-1,3 had 
slightly reduced erosion scores 7 days post-infection and significantly reduced erosion scores 21 days 
post-infection (Fig. 2.6). At 45 days post-infection, despite WT mice having more hydrometra than 
trem1,3-/- mice, both WT and trem1,3-/- mice were able to repair their uterine epithelium (Fig. 2.6). 
Histological scoring revealed no difference in the extent of dilatation or lymphocyte infiltration in the 
uterine horns (Fig. 2.7) at 7-, 21-, and 45-days post-infection. We also observed no difference in PMN or 
mononuclear cell infiltration, dilatation, or epithelial erosion in the oviducts (Fig. 2.8). These data suggest 





While Chlamydia infections can be cured via antibiotic therapy, upper genital tract damage as a 
result of an overly robust host immune response can be irreversible. Understanding the molecular and 
cellular mechanisms that induce tissue damaging inflammation would aid development of adjunctive 
therapies to prevent sequelae. Neutrophils are strongly associated with chronic tissue damage in the 
female reproductive tract during chlamydial infection. In this study we investigated the contribution of 
TREM-1,3, an activation receptor highly expressed on neutrophils, in chlamydial pathogenesis. Using the 
mouse model of genital Chlamydia infection, we demonstrate that TREM-1,3 does not contribute to 
infection control, but contributes to neutrophil-induced pathology in the uterine horns.  
Contribution of TREM-1,3 to chlamydial-immunopathology but not towards infection clearance 
are consistent with other infection models which also rely on a T cell response to combat infection. 
Specifically, mice deficient in TREM-1 expression were able to control Leishmania major and influenza 
infections similar to that of WT while having reduced immunopathology from infiltrating neutrophils 
(21). Similarly, TREM-1 deficient mice infected with LCMV displayed reduced hepatic injury that is 
commonly associated with infiltrating neutrophils (22). The lack of an effect of TREM-1,3 deficiency on 
chlamydial burden is not surprising given Chlamydia spp. are obligate intracellular pathogens, and the 
primary mechanism for control of infection is adaptive Th1 T cells (40-43), while neutrophils are 
dispensable in primary infection and only play a supportive role in secondary infections (6, 43, 44). In our 
infection model, we observed a reduction in neutrophil-associated immunopathology in the uterus during 
chlamydial infection, indicating TREM-1,3’s ability to enhance the tissue damaging inflammatory 
response. However, we did not observe any reduction in oviduct hydrosalpinx formation in TREM-1,3 
deficient mice, suggesting that either TREM-1,3’s role is confined to the uteri or that alternate receptors, 
which contribute to oviduct pathology, such as TLR2 (45), TNF-R (46), and/or IL-1R (47) are too 
damaging in the oviduct to allow for a contribution of TREM-1,3 to be observed. Alternatively, the 




neutrophil-induced damage, masking the contribution of TREM-1,3 on TeM. We speculate that since 
TREM-1,3 synergizes with TLRs to enhance myeloid cell activation (33), blockade of TREM-1,3 in 
combination with TLR2 could enhance the protective effects of TLR2 deficiency, and reveal a 
contributory role for TREM-1,3 in the oviducts. 
Studies have reported reduced neutrophil migration in the absence of TREM-1 signaling (21, 48), 
and a study by Klesney-Tait et al linked TREM-1,3 to neutrophil TeM in the lung, which was essential 
for murine host defense against P. aeruginosa infection. Mice deficient in TREM-1,3 had decreased 
infiltration of neutrophils into the bronchiolar airspace that resulted in increased bacterial burden and 
mortality. They further showed the deficit in neutrophil migration was likely a result of ROS production 
(34). Our results showed some reduction in neutrophil TeM into the uterine horn lumen, but no effect on 
neutrophil or lymphocyte tissue infiltration, or rate of bacterial clearance. The comparatively reduced 
effect that we observed of TREM-1,3 deficiency on neutrophil transmigration suggests additional 
neutrophil receptors are engaged during chlamydial infection to elicit transmigration. Additionally, loss of 
epithelial polarity, cytotoxicity, and barrier disruption induced by chlamydial infection (49) surely 
provides access for neutrophils to migrate into the lumen in the absence of TREM-1,3 activation. 
Interestingly, we observed increased levels of G-CSF in uterine homogenates from trem1,3-/- mice. G-
CSF binds to its receptor G-CSFR on neutrophils. Therefore, we speculate that reduced neutrophils in the 
uterine lumen of trem1,3-/ - mice result in increased unbound detectable G-CSF. In support of this, in 
arthritis and LPS-induced lung injury models, neutrophil recruitment is followed by a reduction in 
detectable G-CSF (50, 51). Although effects of TREM-1,3 on TeM were mild in our model, our data 
revealed a reduction in uterine horn epithelial erosion in TREM-1,3 deficient mice during infection. 
However, the mechanism by which TREM-1,3 promotes epithelial erosion is unclear. We suspect it is a 





It is well-established that the formation and function of uterine glands is critical to support egg 
implantation and fetal growth by providing the necessary nutrients for development (reviewed in (52)). A 
common characteristic of genital chlamydial infections in mice is enlarged fluid-filled uterine glands that 
do not repair themselves, termed hydrometra. This chronic pathology has been previously shown to cause 
obstruction and prevent efficient uterine contraction that aids in fertility in mice (53-55). Here, we report 
a reduction in the number of uterine glands containing PMNs early during infection and a reduction in the 
occurrence of hydrometra formation in the absence of TREM-1,3. The exact mechanism of uterine 
hydrometra formation is not clear. It could be a result of neutrophil inflammation and damage that causes 
excessive epithelial and inflammatory cell debris in the glands, leading to blockade that causes eventual 
fluid accumulation. Epithelial cell death could release DAMPs and PAMPs that lead to further immune 
activation in uterine glands. Our data from trem1,3-/- mice suggest that TREM-dependent epithelial 
erosion resulting from neutrophil TeM likely contributes to hydrometra formation. However, a direct link 
between epithelial erosion and hydrometra requires further investigation. In humans, histopathological 
analysis of Chlamydia-induced endometritis is associated with increased PMNs in the endometrial glands 
(56, 57), making the presence of hydrometra in mice analogous to pathology observed in humans. 
Given the strong association with Chlamydia infections and endometritis (58), more efforts are 
needed to mitigate immunopathology incurred in the endometrium during infection. A common feature of 
chlamydial infection in women is neutrophil infiltration in the lumen of glands in the endometrium (57, 
59), similar to what is seen in the mouse model.  Since TREM-1 has a role in tissue damage in the uteri of 
mice, this receptor may be a suitable therapeutic target to reduce endometrial inflammation during 
chlamydial infection without compromising host defense responses important in infection resolution. 
Further, identification and blockade of other neutrophil innate inflammatory receptors in combination 







Figure 2.1: TREM-1 is expressed on myeloid cells in the genital tract during C. muridarum 
infection.  
C57BL/6J WT (N=5) and trem1,3-/- (N=4) mice were infected with 3 x105 IFUs of C. muridarum and 
genital tracts were harvested 7 days later. Uterine horn cell suspensions were analyzed for TREM-1 
expression in hematopoietic and non-hematopoietic cells by flow cytometry. Representative plots of live 
cell subtypes for WT (A) and trem1,3-/- mice (B) from one of two experiments is shown. All gates were 






Figure 2.2: TREM-1,3 contributes to uterine hydrometra formation during chlamydial infection.  
(A) C57BL/6J WT (N = 5) and trem1,3-/- (N = 4) mice were infected with 3 x105 IFUs C. muridarum. 
Chlamydial shedding was determined from vaginal swabs taken at indicated days post-infection and 
quantified by qPCR using standard curve measuring copy numbers for chlamydial MOMP (ompA) gene. 
Error bars represent mean ± SEM. Data are representative of 3 experiments. (B) H&E staining of 
histological sections of genital tracts from 2 representative mice from each group 45 days post-infection. 
Arrows indicate oviduct hydrosalpinx (open arrows) and uterine hydrometra (solid arrows). Numbers of 
hydrosalpinx in the oviducts and hydrometra in the uteri were quantified in each mouse and data were 
combined from 3 experiments, with N=16 WT and 15 trem1,3-/- (C). Hydrosalpinx incidence was 






Figure 2.3: Trem1,3-/- mice had reduced number of uterine horn glands with polymorphonuclear 
cell presence. 
C57BL/6J WT and trem1,3-/- mice were infected with 3 x105 IFUs C. muridarum and genital tracts were 
harvested 7 days post-infection. Representative H&E staining of histological sections of uterine horn 
glands from WT and trem1,3-/- mice with (solid arrows) and without (open arrows) PMNs. The number of 
glands in the uterine horns containing PMNs were counted in each mouse. Error bars represent mean ± 






Figure 2.4: Immune cell infiltration is not dependent on TREM-1,3 expression in the uterus during 
infection.  
Genital tracts were harvested 7 days post-infection with C. muridarum. (A) Uterine horn tissue 
homogenate was applied to L929 monolayer and IFUs/tissue was calculated 24 hours later. N=6. (B) 
Immune cells populations were quantified from single cell suspension of whole uterine horn tissues by 
flow cytometry. Cells are displayed as percentage of total cell population. Error bars represent mean ± 
SEM. N = 6. (C) Uterine horns were excised from mice 7 days post-infection and tissue homogenates 






Figure 2.5: TREM-1,3 expression contributes to neutrophil transepithelial migration in the uterine 
horn lumens.  
Infected C57BL/6J WT and trem1,3-/- mice were harvested 7- and 21-days post-infection. (A) 
Immunohistochemical staining with anti-neutrophil antibody of representative histological sections 7 days 
post-infection. Neutrophils are highlighted brown using DAB as the detection chromogen and solid 
arrows indicate basal portion of the uterine horn luminal epithelium. (B) Histological sectioning of the 
uterine horns was scored for polymorphonuclear cell (neutrophil) infiltration into the lumen 7 days post-
infection (dpi). 7 dpi: N=13 of 3 experiments combined. 21 dpi: N=14 of 2 experiments combined. 
p<0.01(**). (C) Lavages were collected from excised uterine horns and neutrophil quantification of 
lavages and tissues after lavage determined by flow cytometry. The percent of total neutrophils in the 
lumen is percentage of ratio of lavage neutrophils/lavage and tissue neutrophils. N=14 WT, 12 trem1,3-/-. 
Error bars represent mean ± SEM. (D) In an independent experiment, tissue homogenates were prepared 








Figure 2.6: Absence of TREM-1,3 causes reduced epithelial erosion in mouse uteri early during 
infection.  
Genital tracts from infected C57BL/6J WT and trem1,3-/- mice were harvested 7-, 21-, and 45-days post-
infection. Representative H&E staining of the uterine horn luminal epithelium from histological sections 
of WT and trem1,3-/- mice. Solid arrows indicate intact epithelium and open arrows indicate eroded and/or 
disrupted epithelium. Semi-quantitative scoring of epithelial erosion was performed on all sections. 
Sections were scored from 1-4 as described in the Materials and Methods section. Day 7 post-infection: 
N=12 WT, 13 trem1,3-/- of three combined experiments, 21 post-infection: N=14 of two combined 






Figure 2.7: TREM-1,3 does not contribute to mononuclear cells infiltration in mouse uteri.  
C57BL/6J WT and trem1,3-/- mice were infected with 3 x105 IFUs C. muridarum and genital tracts were 
harvested 7-, 21-, and 45-days post-infection. Histological sectioning of the uterine horns was scored for 
severity of dilatation, and the presence of mononuclear cells as described in the materials and methods 
section. Error bars represent the mean ± 95% confidence interval. 7 days post-infection: N=12 WT and 13 
trem1,3-/- from 3 combined experiments, 21 days post infection: N=14 from 2 combined experiments, 45 





Figure 2.8: Trem1,3-/- mice develop similar oviduct pathology as WT mice.  
C57BL/6J WT and trem1,3-/- mice were infected with 3 x105 IFUs C. muridarum and genital tracts were 
harvested 7-, 21-, and 45-days post-infection. Histological sectioning of the oviducts was scored for the 
presence of PMNs and mononuclear cells into the lumen, the quality of dilatation, and epithelial erosion 
as described in the materials and methods section. Error bars represent the mean ± 95% confidence 
interval. 7 days post-infection: N=12 WT and 13 trem1,3-/- from 3 combined experiments, 21 days post-
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CHAPTER 3 : PRIMARY HUMAN FALLOPIAN TUBE EPITHELIAL CELLS ARE 
RESISTANT TO CHLAMYDIA INFECTION2 2 
SUMMARY 
Chlamydia trachomatis infection of the human Fallopian tubes can lead to damaging 
inflammation and scarring, ultimately resulting in infertility. To study the human cellular responses to 
chlamydial infection, researchers have frequently used transformed cell lines that can have limited 
translational relevance. We developed a primary human Fallopian tube epithelial cell model based on a 
method previously established for culture of primary human bronchial epithelial cells. After protease 
digestion and physical dissociation of excised Fallopian tubes, epithelial cell precursors were expanded in 
growth factor-containing medium. Expanded cells were cryopreserved to generate a biobank of cells from 
multiple donors and cultured at an air-liquid interface. Culture conditions stimulated cellular 
differentiation into polarized mucin-secreting and multi-ciliated cells, recapitulating the architecture of 
human Fallopian tube epithelium. The polarized and differentiated cells were infected with a clinical 
isolate of C. trachomatis, and inclusions containing chlamydial developmental forms were visualized by 
fluorescence and electron microscopy. Apical secretions from infected cells contained increased amounts 
of proteins associated with chlamydial growth and replication, including transferrin receptor protein 1, the 
amino acid transporters SLC3A2 and SLC1A5, and the T cell chemoattractants CXCL10, CXCL11, and 
RANTES. Flow cytometry revealed that chlamydial infection induced cell surface expression of T cell 
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homing and activation proteins including ICAM-1, VCAM-1, HLA class I and II, and IFNGR. Flow 
cytometry and microscopy also revealed FTE cells are highly resistant to infection. We found high basal 
expression of ido1 transcripts in both uninfected and infected FTE cells. Additionally, we were able to 
increase infection with the addition of an IDO1 inhibitor, tryptophan, or indole. This human Fallopian 
tube epithelial cell culture model is an important tool with translational potential for studying cellular 
responses to Chlamydia and other sexually-transmitted pathogens. 
INTRODUCTION 
Chlamydia trachomatis infects more than 1.7 million people in the United States annually and 
cases have continued to rise since 2000 (1). Worldwide, an estimated 131 million new cases are reported 
each year (2). Infection is often asymptomatic. As a result, many women are undiagnosed and 
consequently untreated. Chlamydia trachomatis can ascend to the upper genital tract and infect the 
Fallopian tubes. The resulting inflammation promotes long-term sequalae, such as tubal scarring, ectopic 
pregnancy, and infertility (3). Development of targeted therapies and vaccines to reduce and/or prevent 
such sequalae require improved understanding of the mechanisms that drive Fallopian tube pathology 
during C. trachomatis infection. 
Chlamydia trachomatis is an obligate intracellular Gram-negative pathogen with a unique 
biphasic developmental cycle involving an infectious, non-replicative form called an elementary body 
(EB) and a non-infectious, replicative form called a reticulate body (RB). Infection is initiated by 
attachment and uptake of extracellular EBs to the apical surface of epithelial cells. Once internalized, EBs 
convert into RBs in an endosomal vacuole, which is modified to prevent fusion to lysosomes. The RBs 
replicate within this modified intracellular vacuole, called an inclusion, before converting to EBs later in 
the developmental cycle to propagate infection after release (4). In the female genital tract, infection is 
restricted to mucosal epithelial cells, which respond to infection by secreting proinflammatory cytokines 




While the importance of cytokines and chemokines during genital chlamydial infection has been 
well-described in mouse models and human transformed cell lines (5, 9-12), the response of primary 
human Fallopian tube epithelium to chlamydial infection is less well characterized. Data related to 
chlamydial-epithelial interactions in humans have been gathered using the transformed cervical epithelial 
cell line HeLa. However, their increased metabolic rate, incidence of aneuploidy (13), and non-polar 
secretion of cytokines/chemokines do not mirror the polarized columnar epithelia of the cervix and 
Fallopian tubes (14).  
Two ex vivo models to study epithelial responses to Chlamydia infection in primary cells have 
been established: Fallopian tube explants (15), and polarized epithelial cells cultured directly from 
Fallopian tube explants (16-18). An important barrier to investigation of epithelial cell responses to 
chlamydial infection using tissue from Fallopian tube explants is the inability to distinguish epithelial-
specific contributions from responses of resident immune cells. Similarly, polarized epithelial cell 
cultures generated directly from explants may still include immune cells. These cell populations can 
undermine establishment of pure primary epithelial cell cultures while exposure to danger associated 
molecular patterns (DAMPs) released from dead or dying cells during Fallopian tissue processing could 
impact infectivity or host cellular responses to the pathogens being studied. 
We have developed a primary human Fallopian tube epithelial (FTE) cell culture model which 
supports investigation of cellular responses to pathogens without risk of contaminating immune or 
stromal cells. We expanded isolated FTE cells in a non-proprietary epidermal growth factor-rich medium 
to generate purified FTE cell precursors. These cells were subsequently polarized on porous support 
membranes using an approach adapted from a method used to generate polarized bronchial epithelial cells 
at an air-liquid interface (ALI) (19). Transition to the ALI format resulted in columnar epithelium 
containing mucin-secreting goblet and multi-ciliated epithelial cells that recapitulate the morphology of 
cells previously imaged in human Fallopian tube specimens by histology or scanning electron microscopy 




development, EB to RB transition, RB division, and generation of new EBs. However, we found primary 
FTE cells to be highly resistant to infection. We were able to increase infection rates with the addition of 
LW106 (IDO1 inhibitor), L-tryptophan, or indole to the media. Proteins important for chlamydial growth 
and replication, and neutrophil and T cell chemoattractants, were detected in apical washes of infected 
FTE cell cultures. Further, infected cells increased surface expression of proteins involved in cell-cell 
adhesion and antigen presentation. Together, our data indicate the primary human FTE cell culture model 
provides a useful tool to examine pathogen-driven responses specific to FTE cells in a controlled and 
reproducible fashion. 
MATERIALS AND METHODS 
Isolation, expansion, and polarization of primary human FTE cells 
Fallopian tubes were obtained from healthy pre-menopausal women after elective 
salpingectomies performed at the University of North Carolina Hospital’s Hillsborough Campus. The 
Office of Human Research Ethics at UNC determined that the use of these tissues in this research study 
did not require IRB-approval (IRB#: 15-2805). About 6-10 cm of de-identified tissue was provided. 
Tissues were placed in phenol red-free Ham’s F12 medium (Gibco, 21700075) immediately after surgery 
and refrigerated. Tissues were then transported to the lab on ice and processed on the same day.  
Isolation: The following procedures for isolation of FTE cells from the tissue reflect 
modifications to a protocol for isolation and culture of human airway epithelial cells from human lungs 
(19) . Fallopian tubes were opened with sterile scissors to expose the luminal space, cut into ~1cm 
sections and placed in 30 mL Joklik MEM (Millipore Sigma, M8028) medium containing 2 mL of 10X 
1.0% Protease-0.01% DNase stock (Sigma P5147 and DN-25), 35 µL of gentamicin (50 µg/mL, Gemini 
BioProducts, 400-108), and 175 µL of amphotericin B (250 µg/mL, Gemini BioProducts, 400-104) in 50 
mL conical tubes overnight at 4°C while gently rocking. Tissues were removed and the epithelial cells 




cells were centrifuged at 600 ´ g at 4°C for 5 minutes. Cells were resuspended in Accutase® (Innovative 
Cell Technologies, Inc., AT104) with 0.5 mM EDTA (as supplied) for 30 minutes at 37°C to de-clump. 
RBC lysis was performed with ACK lysis buffer (Gibco, A1049201) as needed per tissue. All isolated 
cells (including precursors) were described as passage 0 (P0), and were counted and resuspended in 
Bronchial Epithelial Cell Growth Medium (BEGM) (19) with supplemental antibiotics (ceftazidime (100 
µg/mL), vancomycin (100 µg/mL), tobramycin (80 µg/mL)) and antifungals (fluconazole (2.5 µg/mL), 
mycamine (20 µg/mL), amphotericin B (1µg/mL)).  
Expansion: To expand epithelial precursors, cells were cultured in BEGM, a epidermal growth 
factor-rich medium (22), on 100 mm tissue culture plates previously coated with 1.5%  PureCol® 
Collagen Type I (Advanced Biomatrix, 5005) at 4-6 ´ 106 cells per plate. The adherent cells were washed 
with PBS at 24 hours to remove dead or unbound cells and debris before replacing the BEGM medium 
with fresh antibiotics and antifungals. After 3 days in culture, FT cells were washed and fresh BEGM 
without supplemental antibiotics or antifungals was applied. Upon reaching ~80-90% confluence (4-7 
days), precursor cells were removed using Accutase® for 30 minutes at 37°C, resuspended in Ham’s F-12 
medium and counted. At this stage, cells were described as P1 and were cryopreserved at 2 ´ 106 cells/mL 
in freezing medium (78% Ham’s F-12, 10% DMSO, 10% FBS, 2% 1.5M HEPES) for future use or 
immediately transferred to collagen coated porous inserts to develop into polarized cultures.  
Non-polarized FTE cultures were obtained by seeding cells at 2 ´ 105 cells/well on a 24 well 
plate, 5 ´ 105 cells/well in 12 well plate, or 5 ´ 104 cells/well in 96 well plate in ALI medium. HeLa and 
OE cells were seeded at the same density and used in parallel as controls in some experiments. HeLa cells 
were cultured in DMEM +10% FBS and OE cells were cultures in DMEM/Ham’s F12 +10% FBS. After 
infection, cycloheximide (500 ng/ml) was added to the HeLa medium to limit overgrowth. Cells were also 
treated with different concentration of LW106 (Sigma SML2400), L-tryptophan (Sigma 93659), or Indole 




Polarization: To develop polarized, differentiated FTE cell cultures, cells were seeded at 2.5 ´ 
105 cells on 0.4 µm PTFE 12 mm inserts (Millipore Sigma, PICM01250) in air-liquid interface (ALI) 
differentiation medium. Inserts were previously coated with 150 µL of 50 µg/mL human placenta 
collagen type IV (Sigma C-7521) (22). Upon reaching 100% confluence (3-5 days), apical medium was 
removed to establish an ALI and to promote multi-ciliated and goblet cell differentiation. Mucoid 
secretions on the apical surface were removed by washing with 100 µL of 37°C PBS twice every 48-72 
hours carefully, making sure that the tip of the pipette did not touch the cells. Media on the basolateral 
side was replaced at the same time. Transepithelial electrical resistance measurements (TEER) were 
obtained using an EVOM2 instrument (World Precision Instruments, Sarasota, FL, USA) with STX2 
electrodes and Ohm resistance was normalized to a cell-free blank and calculated by culture area.  
Chlamydia trachomatis infection of FTE cells  
Chlamydia trachomatis CTE3024 (Serovar E) is a low-passage clinical isolate cultured from an 
endometrial biopsy specimen, using procedures previously described (23), and was propagated in McCoy 
cells in our laboratory. CTE3024 was transformed with either p2TK2-SW2mCherry (24) or 
p2TK2mCherry CmR (Fig. 1.1), generating CTE3024 expressing mCherry (passage 5). CTE3024-
mCherry was also propagated in McCoy cells. CTE3024-mCherry harvested from infected cells was 
treated with 233µg/ml DNAase I (Sigma, D0876) and 2.1mg/ml RNAase A (Sigma, R5503) for 60 
minutes at 37°C and then centrifuged at 39,200  ´ g  over a 32% Renografin density gradient to remove 
cellular debris and prepare concentrated purified EB/RB suspensions. Titers of chlamydial stocks were 
determined by infection of L929 monolayers and determining inclusion forming units (IFUs) as 
previously described (25, 26). Primary FTE cell cultures, 12-15-day old cultures (7-10 days post-ALI) 
were prepared for infection by removing mucus by washing the apical surface with 37°C PBS 4 times for 
20 minutes each. Inserts were placed in a 24 well plate containing 1 ml of ALI medium and cells were 
infected at 10 MOI for one hour by centrifuging the plate at 1800 ´ g at 37°C. Apical medium was 




of FTE cells with 10 mM dithiothreitol for 20 min prior to infection or treatment of cells with 10 nM ß-
Estradiol (Tocris 2824) and/or 400 nM Progesterone (Tocris 2835) for 24-72 hours prior to infection. 
Immunostaining and confocal microscopy 
Cells were fixed with methanol-free 4% formaldehyde prepared from 20% paraformaldehyde, for 
15 minutes at room temperature (RT). Fixed cells were washed with PBS three times and permeabilized 
with 0.2% Triton X-100 (Sigma, T8787) for 30 minutes. Permeabilized cells were washed 3 times with 
PBS and blocked with a solution comprised of 1% Fish gelatin (Sigma, G7765), 0.1% BSA (Sigma, 
A4503), and 0.1% Triton X-100 (Sigma, 9002-93-1) at 4°C in PBS, overnight. Immunostaining with 
primary antibodies was carried out in blocking solution overnight at 4°C. Cilia were stained with rat anti-
human aTubulin (Sigma, MAB1864) at 5 µg/ml for cilia, mouse anti-human MUC1 (ThermoFisher, 
MA5-13168) at 3 µg/ml for mucus, rabbit anti-human ZO-1 (ThermoFisher, 40-2200) at 2 µg/ml for tight 
junctions, and/or with mouse anti-chlamydial LPS (BioRad, MCA2718) at 3 µg/ml for chlamydial 
inclusions. HeLa cells and non-polarized FTE cells were stained with Rabbit anti-RFP (Rockland, 600-
401-379) at 1:1000 to enhance mCherry fluorescence. Cells were washed 3 times with 20% blocking 
solution in PBS. Secondary antibodies used were goat anti-rat 488 (Abcam, AB150165) at 2 µg/ml, goat 
anti-rabbit 488 (Invitrogen, A11034) at 4 µg/ml, goat anti-rabbit 594 (Invitrogen A11037) at 1µg/ml, 
and/or donkey anti-mouse AF546 (Invitrogen, A10036) at 4 µg/ml. Secondary antibodies were applied for 
2 hours at room temperature, followed by 3 washes with PBS. Cultures were counterstained for actin with 
Phalloidin AF647 (Invitrogen, A22287) at 1:50 dilution and DNA with Hoechst 33342 (Invitrogen 
H1399) 1:200 dilution for 30 minutes at RT. Membranes were carefully excised from inserts with a #12 
scalpel and mounted with ProLong Gold Anti-Fade Mount (Invitrogen, P10144). Fluorescently labeled 






Transmission Electron Microscopy  
CTE3024-mCherry-infected FTE cell cultures grown on inserts were fixed in 2% 
formaldehyde/2.5% glutaraldehyde/0.15M sodium phosphate buffer, pH 7.4, for 1 hour at room 
temperature and stored in fixative at 4˚C overnight to several days. Following three rinses with 150 mM 
sodium phosphate buffer, pH 7.4, the cells were post-fixed with 1% osmium tetroxide/150 mM sodium 
phosphate buffer for 1 h. After washes in deionized water, cells were dehydrated using increasing 
concentrations of ethanol (30%, 50%, 75%, 100%, 100%, 10 minutes each) and embedded in Polybed 812 
epoxy resin (Polysciences, Inc., Warrington, PA). Cross sections of the filter/cell layer were ultrathin 
sectioned at 80 nm thickness using a diamond knife and a Leica Ultracut UCT ultramicrotome (Leica 
Microsystems, Inc., Buffalo Grove, IL). Ultrathin sections were collected on 200 mesh copper grids and 
stained with 4% aqueous uranyl acetate for 12 minutes followed by Reynolds’s lead citrate for 8 minutes 
(27). Samples were observed with a JEOL JEM-1230 transmission electron microscope operating at 80 
kV (JEOL USA, Peabody, MA) and digital images acquired using a Gatan Orius SC1000 CCD camera 
and Gatan Microscopy Suite 3.0 software (Gatan, Inc., Pleasanton, CA). 
Scanning Electron Microscopy  
For SEM, the cells were fixed and dehydrated as above and transferred in 100% ethanol to a 
Tousimis Samdri-795 critical point dryer (Tousimis Research Corporation, Rockville, MD). Samples 
were critical point dried with liquid carbon dioxide as the transitional solvent. The filter membrane was 
removed from the well insert support and mounted cell side up onto 13 mm diameter aluminum stubs 
with carbon adhesive tabs. The samples were coated with 10 nm of gold/palladium alloy (60Au:40Pd) 
using a Hummer X Sputter Coater (Anatech USA, Union City, CA). Images were taken using a Zeiss 
Supra 25 FESEM operating at 5 kV with the Inlens secondary electron detector, 30 μm aperture, and 





Gene expression and Luminex Assay 
Polarized FTE cells were processed for RNA using miRCURYTM isolation kits (Exiqon).  RNA 
(500 ng) was processed for reverse transcription and quantitative PCR using SsoAdvanced SYBR mix 
(Bio-Rad) using a CFX iCycler as previously described (25). Primer sequences for chlamydial gene 
expression were selected based on genes annotated in the C. trachomatis D/UW-3/Cx genome (28) and 
are as follows: omcA (F’ CTGCTTTACTCGCTGCTTTATG, R’ GATAGGTGCGCATGGATCTT), ndk 
(F’ CTCTGGTCCTGTTGTAGTAATGG, R’ ACCTTCCGCAGCTTCTTTAG), uhpC (F’ 
CTTAGAGGAAGAGGCAGAAAGAG, R’ GCCATGCGAACCACATAAATAA), euo (F’ 
CTACACGCATTGGTGCTATGA, R’ CTACACGCATTGGTGCTATGA), glgA (F’ 
GCATCATCGCTTGTGTAGATTG, R’ AGCAACTGCTTTCTCCTACTT), hctA (F’ 
AAGCTAAAGCTGCTGCTAAGA, R’ GTTGGTTTGACCTTTGCTTTAGT). Gene expression was 
normalized using omcA rather than 16 and 23S rRNA because these transcripts were carried over in the 
high MOI needed to infect the FTE. Gene expression for ido1 was measure using the following primers: 
F’ ACGGTCTGGTGTATGAAG, R’ CTAATGAGCACAGGAAGTTC. Gene expression in FTE cells 
relative to L929 cells or HeLa cells was determined by ΔΔCT method using BioRad MaestroTM software. 
Luminex assays were performed on apical washes and basolateral conditioned medium using a multiplex 
panel containing 48 cytokines/chemokines as described previously (29). Apical washes were collected 48 
hours post-infection by applying 100 µL 37°C PBS for 5 minutes twice and aspirating from mock-
infected and infected FTE cell cultures. Basolateral media (1 mL) was also collected. Luminex data were 
not adjusted by FDR due to small sample size. 
Mass spectrometry 
Mass spectrometry-based proteomic analysis was performed on apical washes of 4 mock-infected 
and 4 CTE3024-mCherry-infected FTE cell cultures 24 hours post-infection. 200 μl of apical FTE cell 




(30). Proteins were digested overnight using trypsin (20 ng/μl) in 50 mM ammonium bicarbonate at 37°C. 
The resulting peptide digests were eluted using Amicon Ultra 4 10 kDa spin filters. Peptides were vacuum 
freeze-dried and dissolved in 25 μl of 1% acetonitrile and 0.1% trifluoroacetic acid. Five microliter of 
solubilized peptide material was injected for proteomic analysis in a Q Exactive (Thermo Scientific) mass 
spectrometer coupled to an UltiMate 3000 (Thermo Scientific) nano HPLC system, and data acquisition 
was performed as described previously (31). The acquired raw data was processed using the Proteome 
Discoverer 1.4 (Thermo Scientific) software and searched against the UniProt protein database (Homo 
sapiens, August 2015) using the SEQUEST search engine with parameters set as follows: 10 ppm mass 
accuracy for parent ions and 0.02 Da accuracy for fragment ions, with 2 missed cleavages allowed. 
Carbamidomethyl of cysteine was specified as a fixed modification and oxidation of methionine was 
specified in SEQUEST as a variable modification. Scaffold 4.7.5 (Proteome Software Inc.) was used to 
validate MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they 
could be established at greater than 95.0% probability by the Scaffold Local FDR algorithm. Protein 
identifications were accepted if they could be established at greater than 99.0% probability and contained 
at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm (32). 
Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone 
were grouped to satisfy the principles of parsimony. Relative protein quantification was performed by 
summarizing the intensities of identified precursor ions for each protein as total precursor intensities. 
Individual protein intensities were normalized to the total intensity of all identified proteins in each 
sample. Analysis of statistical significance between the Chlamydia-infected and mock-infected control 
group were determined on pairs for each donor using paired t-test analysis.  
Flow cytometry  
Mock-infected and CTE3024-mCherry-infected HeLa and FTE cells were removed from cultures 
36- or 48-hours post-infection using Accutase® for up to 1 hour at 37°C. Cells were washed and 




stained for surface markers by incubating with manufacturer recommended concentrations of either 
mouse IgG anti-ICAM1-PacBlue (Biolegend 322715), anti-VCAM1-FITC (BD 551146), anti-TLR2-APC 
(Biolegend 392304), anti-IFNGR-PE (Biolegend 308606), anti-HLA A, B, C-AF700 (Biolegend 311438), 
or anti-HLA DR, DP, DQ-PerCP/Cy5.5 (Biolegend 361710) for 30 minutes at room temperature in the 
dark. Cells were then washed three times with cell stain buffer and fixed with 2% formaldehyde. Cells 
were analyzed on Attune NxT cytometer at the UNC Flow Cytometry Core Facility. Data analysis was 
performed using Cytobank (33). The percentage of infected cells was determined by drawing gates on 
~1% mock-infected cells to include infected cells whose inclusions may be smaller than others and have a 
decreased Mean Fluorescent Intensity (MFI). The percentage of infected cells was then normalized to the 
mock-infected percentage. 
RESULTS 
Primary human FTE cells polarize, secrete mucus, have beating cilia, and form tight junctions. 
To establish a primary human FTE cell culture that recapitulates native morphology and function we 
isolated and expanded cells from Fallopian tube explants (N=12 donors) to obtain undifferentiated 
epithelial cell populations. Purified epithelial precursor cells ranged from 15-200 million cells/donor, with 
4 donors yielding >140 million cells. These cells were either cryo-preserved for future use or cultured 
immediately on microporous membranes. When confluent (3-5 days), overlying medium was removed 
from the apical surface to establish an ALI (Fig. 3.2A). Multicellular, cobblestone-like structures were 
observed by light microscopy as early as 3 days after transition to ALI (post-ALI). These structures were 
maintained through 45 days post-ALI (Fig. 3.2B) without medium leakage from the basolateral to apical 
surface, indicating continuous barrier integrity. Additionally, we observed cilia movement as early as 7 
days post-ALI and through 45 days. Hematoxylin and eosin staining of histological sections at 21 days 
post-ALI revealed ciliated and non-ciliated polarized columnar epithelial cells, while Alcian blue and 
Periodic acid Schiff staining indicated mucin production at the apical surface (Fig. 3.2C). Polarized FTE 




Scanning electron microscopy of cells at 24 days post-ALI revealed structures consistent with cilia and 
microvilli at high density (Fig. 3.3A). Using antibodies directed against a-tubulin, a structural protein in 
cilia, and MUC1, a major protein in mucoid secretions (34), we confirmed their expression by FTE cells 
at 12 days post-ALI (Fig. 3.3B). Junctional complexes were observed with transmission electron 
microscopy between adjacent cells 24 days post-ALI (Fig. 3.3C). Tight junctions between the polarized 
columnar FTE cells were detected as early as 5 days post-ALI after immunostaining for ZO-1, a protein 
found in epithelial cell tight junctions (35, 36) (Fig. 3.3D). Transepithelial electrical resistance (TEER) 
was transiently decreased after removal of the apical medium. However, FTE cells subsequently 
maintained consistent TEER (>157 ± 9.7 W*cm2), starting 7 days post-ALI (11 days post-seeding) (Fig. 
3.4). Thus, donor-derived epithelial precursors established polarized ciliated and mucin producing cells 
with tight junctions, mimicking the epithelial morphology of human Fallopian tube explants (15, 16) after 
transition to ALI.  
Chlamydia trachomatis infects and replicates in FTE cells. Polarized FTE cells 8-10 days post-
ALI were inoculated with a low-passage, endometrial isolate of C. trachomatis strain CTE3024 (Serovar 
E) transformed with a chimeric plasmid encoding the fluorescent protein mCherry. Chlamydial inclusions 
were visualized by confocal microscopy 48 hours post-infection by immunofluorescent staining using a 
monoclonal antibody directed against chlamydial LPS (Fig. 3.5A). Inclusions were unevenly distributed 
throughout the culture and this ‘patchiness’ was not remediated with an increased multiplicity of infection 
(MOI=10) and centrifugation. Photoimaging of infected cultures for quantitation of infection rate by 
microscopy was compromised by uneven infection of the FTE while the distribution of chlamydial 
inclusions to multiple planes within cells made inclusion counts of infected regions uninterpretable. 
Therefore, we used flow cytometry to quantitate infection rates. Flow cytometry of FTE cells 48 hours 
post-infection revealed 4.43% ± 0.26% of the cells were mCherry-positive (Fig. 3.5B), suggesting a low 
infection rate. To compare infection rates quantitated by flow cytometry to microscopy, non-polarized 




post-infection. We observed low infectivity rates by both flow cytometry and immunofluorescent 
microscopy with no significant differences in the percentages of infected cells (Fig. 3.6).  Inoculations 
using highly characterized strains frequently used for cell culture studies such as C. trachomatis, 
L2/434/Bu or D/UW-3/Cx, did not improve the infection rate in polarized FTE cells (data not shown). 
Treatment of polarized FTE cells with progesterone and estrogen or washing the cells with the mucolytic 
agent, dithiothreitol, also did not improve infection rates (data not shown). Interestingly, infection with 
CTE3024-mCherry did not destroy the structural integrity of polarized FTE cells when cells remained in 
culture for up to 32 days (data not shown). This was reflected in TEER measurements that were 
unchanged in infected cells compared to mock-infected cells (Fig. 3.4).  
Transmission electron microscopy of infected polarized FTE cells revealed inclusions containing 
small, electron dense EBs and larger, less dense RBs, indicating conversion of EB to RB by 24 hours 
post-infection. Dividing RBs were observed inside inclusions at 48 hours post-infection. We observed 
increased numbers of EBs compared to RBs in the inclusions 72 hours post-infection, suggesting 
conversion of RBs to new EB progeny (Fig. 3.5C). Consistent with these observations, transcription of 
chlamydial genes was detected by quantitative RT-PCR at 24 hours post-infection at levels comparable 
with those detected in infected fibroblast monolayers.  Specifically, no difference was detected between 
high (ndk) or low level constitutively expressed (uhpC, secA) genes in either cell type. Transcription of 
‘late’ developmental genes, hctA and glgA, appeared mildly elevated but expression of the developmental 
regulator euo was unaltered (Fig. 3.5D). Overall, detection of chlamydial forms and gene expression 
indicated that chlamydial development was supported by FTE, although infection rate was low.  
FTE cells respond to C. trachomatis infection by releasing amino acid and iron transporters and 
chemokines, and upregulating cell adhesion molecules. Apical culture washes were collected 24 hours 
post-infection from mock-infected and infected cultures of four donors to characterize their innate 
response to chlamydial infection by mass spectrometry-based proteomics. Host-derived proteins whose 




are presented in Table 3.1. The mucin proteins, MUC1, MUC4, MUC5AC, MUC5B, and MUC16 were 
abundant in both mock-infected and infected cultures, and their levels were unaltered by infection. In 
apical washes from Chlamydia-infected cells, we observed increases in the amino acid transporter 
SLC3A2 and the iron transporter TFRC, neutrophil chemokines (CXCL1 and CXCL8), proteins involved 
in cell cycle regulation (TSG101), metabolism (CPS1), and the multifunctional transmembrane 
glycoprotein, Basigin (Table 3.1). In contrast, proteins that were significantly downregulated in 
secretions from infected cells included those involved in host protein synthesis and post-translational 
modification (EEF1A2, RPS25, RPL35, DARS, and GALNT1), intracellular trafficking (SNX2), fatty 
acid metabolism (DECR1), retinoic acid transport (CRABP2), antiviral response (PARP4), and TLR 
signaling (TMED7-TICAM2).   
To investigate the innate inflammatory responses of FTE cells to C. trachomatis infection, apical 
washes and basolateral medium were tested for the presence of cytokines and chemokines by Luminex 
bead array 48 hours post-infection with CTE3024-mCherry. Washes collected in parallel from mock-
infected cells were used as controls. Increased levels of CXCL10, CXCL11, and RANTES were detected 
in the apical washes of infected FTE cells compared to mock-infected (Fig. 3.7A), with no significant 
change in basolateral cytokines or chemokines (data not shown). Many of the pro-inflammatory and/or 
signaling proteins probed for were below the level of detection, possibly a result of the overall low level 
of infection and dilution in washing solution or medium. To examine responses specific to cells 
containing a chlamydial inclusion, we infected FTE cells with CTE3024-mCherry, then removed the cells 
48 hours post-infection from their underlying membrane before staining them with antibodies to various 
cell surface molecules. Flow cytometry analysis of mCherry positive-cells revealed significantly 
increased expression of ICAM-1, VCAM-1, TLR2, IFNGR, and HLA class I and II molecules compared 
to mCherry negative-cells of the same culture (Fig. 3.7B). We did not detect significant differences in 




FTE cells are resistant to chlamydial infection as a result of high IDO expression. Upon 
infection, immune cells are recruited to the site of infection. The primary method to clear infection 
involves the release of IFNg from immune cells to bind to IFNGR on the surface of infected epithelial 
cells (reviewed in (37)). Consequently, downstream signaling initiates production of indoleamine 2,3 
dioxygenase (IDO), which breaks down tryptophan stores and starves Chlamydia. Although the canonical 
pathway for IDO production requires IFNg, we determined basal ido1 mRNA expression 24 hours post-
infection in HeLa cells and compared them to primary FTE cells and the human oviduct epithelial cell 
line OE. Interestingly, we found OE cells and primary FTE cells had higher expression of ido1 compared 
to HeLa cells (Fig. 3.8A), that was not increased in response to infection. To determine if this increased 
expression affected chlamydial infectivity, we treated FTE cells with either the IDO small molecule 
inhibitor LW106, tryptophan, or indole for 48 hours and then infected them with C. trachomatis. In a dose 
dependent manner, we found that all three treatments led to increased infection rates.   
Overall, our findings demonstrate that FTE cells respond to chlamydial infection by increasing 
expression of host proteins that support chlamydial growth, cellular adhesion, microbial detection, and 
immune responsiveness, as well as increasing apical secretion of several chemokines. Interestingly, the 
cells also responded by decreasing several host proteins directly involved in cellular protein synthesis, 
metabolism, and immune signaling. Further, FTE cells have high basal expression if IDO that reduces 
cellular susceptibility to infection.  
DISCUSSION 
Genital epithelial cell responses to Chlamydia infection have been studied using transformed cell 
lines, and mouse models of infection. Data from these models have greatly improved our understanding 
of chlamydial pathogenesis. However, limitations of these approaches include potential for decreased 
responses in primary transformed cell lines to chlamydial infection (38-40). Further, responses resulting 




IFNg-mediated inhibition of chlamydiae (41-43), need further validation in a relevant human cell type. 
Development of therapies and/or vaccines that limit or prevent Fallopian tube pathology during genital 
chlamydial infection requires an improved understanding of pathogen-host responses that occur during 
species-specific infection of this vulnerable tissue.  To advance study in all these areas, we have generated 
a primary human FTE cell culture model that recapitulates native cell morphology with polarized multi-
ciliated and mucin-producing cells. Further, C. trachomatis infection of FTE cells induces expression of 
proteins associated with chlamydial growth, secretion of chemokines, and expression of cell adhesion and 
immune response molecules, indicating the translational potential for this model to study chlamydial 
pathogenesis. 
Our method has distinct advantages over previously developed approaches to polarize primary 
human FTE cells (16-18), when harvested FTE cells were directly cultured in microporous supports 
immediately after extraction/dispersion from Fallopian tube tissue. First, we expand FTE cell precursors 
over several days. This removes dead and terminally differentiated cells collected after enzymatic 
digestion and luminal scraping, limiting exposure to DAMPs released from dead cells which could 
dysregulate cellular responses during insert seeding and polarization. Second, expansion of FTE cell 
precursors enables the cryopreservation of relatively large numbers of viable cells and the generation of a 
biobank with multiple donors. Following cryopreservation and subsequent recovery, these cells polarize 
into mucin-secreting goblet and multi-ciliated cells and maintain tight junctions after transition to ALI. 
The proteomic analysis of apical washes revealed peptides corresponding to mucin proteins including 
MUC5AC, MUC5B, MUC4, MUC16, and MUC1. A previous study did not detect mRNA for MUC5AC, 
MUC5B, or MUC4 in human Fallopian tube explants (34). It is possible that we detect these proteins in 
our cell culture system due to enrichment of mucins or lack of cell-extrinsic regulators of secretion during 
in vitro culture.  However, consistent with Gipson et al (44), we did not detect peptides derived from 




Previous studies have demonstrated C. trachomatis infection and reported responses to infection 
in polarized endometrial and cervical cells (38, 45, 46). We now extend these investigations by profiling 
the responses of the human Fallopian tube epithelium, where infection can lead to irreversible sequelae. 
However, we observed a low percentage of infected FTE cells despite multiple vigorous washings with 
PBS with and without mucolytics, such as dithiothreitol, and hormonal treatment. Further, we were only 
able to establish infection by use of a high MOI and centrifugation as previously reported for primary 
cervical and endometrial cells (38, 46) (Fig 3.5B). One explanation could be host cell-cycle state. 
Previous studies using other mucosal pathogens indicate surface proteins utilized for entry into the host 
cell are differentially expressed during specific phases of the cell cycle (47-49), thereby indicating host 
cells are more susceptible to infection during particular phases of the cell cycle. Interestingly, we 
observed similar low infection rates in non-polarized FTE cells (Fig. 3.6A-C) compared with polarized 
FTE cells (<10%) (Fig. 3.5B), suggesting that morphological changes have a minimal role in C. 
trachomatis infectivity. Our data corroborate the low infection rates seen in Fallopian tube explants (50). 
Interestingly, we observed high basal expression of ido1 in both primary FTE cells and transformed FTE 
cells (OE) compared to HeLa. IDO expression is normally increased with IFNGR signaling in response to 
IFNg from NK and T cells. However, our culture did not contain immune cells, suggesting cells from the 
Fallopian tube express IDO constitutively. In support of this, IDO staining in Fallopian tube explants 
revealed high expression of IDO1 in epithelial cells (51). The low infection rates observed for FTE cells 
in vitro may explain the relatively low incidence of long-term tubal complications observed in vivo in 
women (52-54) despite the high prevalence of chlamydial infection (1). We acknowledge that our model 
lacks immune cells or cytokines present in vivo, which can disrupt the ordered epithelium and promote 
spread of infection to neighboring cells; a topic for future investigation. 
Once internalized, the chlamydial developmental cycle appeared normal with respect to inclusion 
formation, differentiation to RB, gene transcription and generation of new EB within polarized FTE. The 




chlamydial sensing of the cellular environment, highly abundant glgA transcripts have been detected in a 
clinical cervical specimen (55) and anti-chlamydial glycogen synthase antibody was prevalent in a large 
human cohort (56). Alternatively, these increases may be artifacts of RNA carry-over from the high MOI 
needed to achieve infection. These preliminary observations appear to be consistent across donors and 
nevertheless highlight the potential that polarized FTE can be used to study chlamydial gene expression 
effectively ex-vivo. 
We observed mature inclusions that contained both chlamydial developmental forms in both 
multi-ciliated and non-ciliated cells (Fig. 3.5C). Our results are consistent with prior observations of 
chlamydial inclusions in secretory (57) and ciliated cells (50, 58) by electron microscopy. Whether 
mucin-producing cells or ciliated cells are more susceptible to infection, and whether these cells respond 
differently to infection remains to be determined. Although chlamydial inclusions were observed in only a 
fraction of cells, infection led to significant changes in the content of proteins in apical washes. Consistent 
with a previous study (59), increased levels of amino acid transporters SLC3A2 and SLC15A (p=0.06) 
(Table 3.1) were observed in washes from cultures of infected cells. SLC3A2 is a transporter for large 
neutral amino acids, such as tryptophan, while SLC1A5 is a transporter for glutamine. Both are important 
for chlamydial replication (59-61). We also observed increased levels of TFRC, which is responsible for 
iron uptake. Iron is also essential for chlamydial growth and replication (62, 63). These data suggest the 
increase of SLC3A2, SLC1A5, and TFRC could be actively modulated by Chlamydia. The detection of 
neutrophil chemoattractants, CXCL8 (IL-8) and CXCL1 in apical washes from infected cells was 
expected given many reports of the release of these proteins from Chlamydia-infected cells in vitro (5) 
and early on during in vivo infection (6). Our failure to detect these proteins in the basolateral medium 
from infected FTE cells was likely due to dilution effects. Proteins that were downregulated in apical 
secretions of infected cells are involved in host protein synthesis and post-translational modification, 
intracellular trafficking, fatty acid metabolism, retinoic acid transport, the antiviral response, and TLR 




are known to dysregulate elements of host protein synthesis (64), upregulating factors that benefit 
bacterial growth and replication (59) and downregulating factors that may be detrimental to survival (65). 
We detected increased levels of the chemokines CXCL10, CXCL11, and RANTES in the apical 
washes of infected FTE cell cultures. CXCL10, CXCL11 and RANTES are chemoattractants for multiple 
immune cell types, including T cells (66-69). We have previously detected these proteins in cervical 
secretions from C. trachomatis infected women (6) and CXCL10 mRNA in endometrial biopsies of 
women with endometrial infection (29). Multiple studies have established that an adaptive CD4 Th1 T 
cell response is essential to combat chlamydial infection (70-75). Thus, it is likely that secretion of these 
chemokines serves a protective role. We did not detect a significant increase in many cytokines frequently 
associated with chlamydial infection in epithelial cells, such as IL-6, CXCL8 (IL-8), CXCL1 (GROa), 
GM-GSF, or TNFa (5, 38), likely a result of the low levels of infection. However, we did detect peptides 
for CXCL8 and CXCL1 by mass spectrometry (Table 3.1). Similarly, infection did not influence the 
abundance of any apically-secreted mucins.  
We observed increased cell surface expression of the adhesion molecules ICAM-1 and VCAM-1 
in Chlamydia-infected FTE cells, which were also upregulated in human and mouse genital tracts during 
chlamydial infection (76-78). Both HLA class I and II proteins were increased on the surface of infected 
FTE cells 48 hours post-infection. Prior studies suggested C. trachomatis decreases HLA class I and II 
expression (79-81), a process possibly mediated by the chlamydial secreted protease, CPAF (82).  
However, a subsequent study failed to detect altered HLA expression in response to Chlamydia infection 
(83) and the investigators suggested that CPAF might instead degrade chlamydial peptides to impair 
pathogen recognition by the adaptive immune system. Collectively, increased expression of ICAM-1, 
VCAM-1, IFNGR, and HLA class I and II indicate FTE cell cultures may be useful for the study of T 





In conclusion, the findings of this study indicate that polarized FTE cell cultures are a valuable 
tool to study chlamydial infection mechanisms, cellular responses to C. trachomatis infection, and they 
can be used in future studies to examine epithelial-immune cell interactions. Furthermore, this approach 
provides a mechanism to biobank samples of FTE cells that will allow researchers to study human genetic 
variation that may modulate responses to Chlamydia infection. The FTE cell culture model also enables 






Table 3.1: Differential levels of proteins in apical washes of infected cells at 24 hours post-
infection detected by mass spectrometry 
Protein Gene name Fold  P value 
Carbamoyl-phosphate synthase, mitochondrial CPS1 INF 0.011 
Growth-regulated alpha protein CXCL1 42 0.050 
4F2 cell-surface antigen heavy chain SLC3A2 SLC3A2 25 0.005 
Transferrin receptor protein 1 TFRC 8.4 0.040 
Basigin BSG 4.6 0.024 
Interleukin-8 CXCL8 4.3 0.005 
Tumor susceptibility gene 101 TSG101 2.9 0.033 
    
Elongation factor 1-alpha 2 EEF1A2 0.4 0.013 
2,4-dienoyl-CoA reductase, mitochondrial DECR1 0.4 0.025 
40S ribosomal protein S25 RPS25 0.4 0.048 
Polypeptide N-acetylgalactosaminyl transferase GALNT1 0.3 0.009 
Poly [ADP-ribose] polymerase 4 PARP4 0.3 0.018 
TMED7-TICAM2 TMED7-TICAM2 0.3 0.035 
Cellular retinoic acid-binding protein 2 CRABP2 0.3 0.045 
Sorting nexin-2 SNX2 0.2 0.038 
60S ribosomal protein L35 RPL35 0.2 0.040 
Aspartate-tRNA ligase, cytoplasmic DARS 0.2 0.044 
P value is from a paired T test with mock-infected and infected FTE cells from 4 donors. Shaded wells 
indicate proteins increased and non-shaded cells indicate proteins decreased in infected cells compared 







Figure 3.1: Map of p2TK2mCherry CmR transformed into C. trachomatis CTE3024.  






Figure 3.2: Primary human FTE cells cultured in an ALI polarize and secrete mucins.  
A: Simplified model of the procedure to generate primary human FTE cell cultures. Fallopian tubes were 
obtained from women undergoing elective salpingectomies. Fallopian tubes were opened, diced into 
pieces, enzymatically digested, and epithelial cells were obtained by gentle scraping of the lumen. 
Primary passage (P0) cells were then expanded on collagen coated tissue culture dishes in a growth 
factor-rich medium, followed by dissociation and seeding of P1 cells on inserts or cryopreserved for later 
use. Creation of ALI was induced on inserts by removing medium from the apical surface, which 
promoted epithelial polarization and cell differentiation. Images created with BioRender. B: Cobblestone-
like structures in FTE cell cultures were observed by phase contrast light microscopy 3 days post-ALI, 
which was maintained through 45 days post-ALI. C: Columnar polarized multi-ciliated and secretory 
cells were observed by H&E staining and mucopolysaccharides were observed by AB/PAS staining of 






Figure 3.3:Primary human FTE cells cultured in an ALI form cilia, produce mucin-rich secretions, 
and form tight junctions.  
A: Mucin, cilia, and microvilli were observed by SEM on FTE cells 24 days post-ALI. Arrows indicate 
mucin (red), microvilli (yellow), and cilia (green). B: Mucin and structural protein of cilia were immuno-
stained and observed by immunofluorescence in a single plane with individual channels (left) and a 
merged image (right) at 12 days post-ALI. Phalloidin for filamentous actin (white), a-Tubulin for cilia 
(green), MUC1 for mucin (red), and DAPI (blue). Scale bars = 20µm. C: Tight junctions were observed 
by TEM of a cross section of an FTE cell junction 24 days post-ALI. Black arrows indicate tight 
junctions. D: Presence of the structural tight junction protein ZO-1 was observed by immunofluorescence 
at 5 days post-ALI (anti-ZO-1, green). Image contains DAPI staining by an extended focus view of the 






Figure 3.4: FTE cells maintain TEER after polarization, despite Chlamydia infection.  
Cells were transitioned to ALI 4 days after seeding, N = 5 cultures. TEER measurements were obtained at 
the indicated time points from uninfected, mock-infected, or cells infected with CTE3024 mCherry (10 
MOI). Uninfected: N = 11 cultures prior to infection and 5 post infection, Infected or mock: N = 3 






Figure 3.5: Chlamydia trachomatis infects polarized FTE cells and completes its developmental 
cycle.  
Primary human polarized FTE cells were infected with CTE3024-mCherry (10 MOI). A: 
Immunofluorescent microscopy of a representative culture stained with DAPI (blue), Phalloidin (white), 
anti-chlamydial LPS (red), and anti-a-Tubulin (green) 48 hours post-infection. B: Percentage of infected 
cells was determined by flow cytometry. Concatenated flow cytometry dot plots of mock-infected (left) or 
infected (right) cultures measuring mCherry expression 48 hours post-infection. N=3 donors. Percentages 
in gate are ± SD. C: Developmental cycles were observed by TEM at 24-, 48-, or 72-hours post-infection. 
Arrows indicate elementary bodies (black), reticulate bodies (white), or dividing reticulate bodies (red). 
D: Polarized FTE (N=5 donors) or L929 monolayers (N=2) were infected with CTE3024-mCherry. Total 
RNA was harvested 24 hours after infection, cDNAs generated, and assayed by qPCR. Data were 
normalized to omcA and gene expression is shown relative to L929 cells. Statistical analysis performed 






Figure 3.6: Quantification of infection in FTE cells by flow cytometry is comparable to fluorescent 
microscopy.  
HeLa cells and non-polarized FTE cells were cultured on coverslips in 24-well plate and 12 well plate. 
Cells were either mock-infected with media alone or infected with CTE3024-mCherry (10 MOI). HeLa 
cells were cultured with cycloheximide (CHX)-containing medium (500 ng/mL) to prevent over 
expansion. Cells on coverslips were fixed for microscopy and cells in 12-well plates were harvested 36 
hours post-infection to evaluate infection rates. A: Representative immunofluorescent microscopy images 
of cultures stained with DAPI (blue) and anti-RFP (red) with drawings of DAPI and mCherry outlined 
particles quantified by ImageJ software. B: Percentage of infected cells in HeLa and non-polarized FTE 
was determined by flow cytometry. Dot plots of mock-infected or infected HeLa (N=1) and non-polarized 
FTE (concatenated, N=3 donors) measuring mCherry expression. Percentages in gate are ± SD. C: Bar 
graph of percent of infected cells as determined by fluorescence microscopy from A and flow cytometry 






Figure 3.7: FTE cells respond to C. trachomatis infection by increasing secretion of cytokines and 
expression of surface proteins.  
Primary human polarized FTE cells were infected with CTE3024-mCherry (10 MOI). A: Luminex assay 
of apical secretions from mock-infected and infected cultures 48 hours post-infection. Individual dots 
represent each donor (N=3). Statistical analysis performed using paired T test. *, P < 0.05. B: Mean 
Fluorescent Intensities (MFI) of surface protein expression in mock-infected and infected cultures 
measured by flow cytometry 48 hours post-infection. The infected culture was then gated for mCherry - 
(Ct-) and mCherry + (Ct +) cells. N=3 donors with 2 replicates per donor. Statistical analysis performed 






Figure 3.8: Primary FTE cells are resistant to infection due to high ido1 expression  
A: Polarized FTE cells from 3 donors (FT003O, FT005L, FT0012), Hela, and OE cells were infected with 
CTE3024-mCherry. Total RNA was harvested 24 hours after infection, cDNAs generated, and assayed by 
qPCR for ido1 gene expression. Gene expression is shown relative to infected HeLa cells. Bars are mean 
of two PCR replicates. B,C,D: FTE cells were cultured in 96-well plates. Cells were treated with media 
alone or media containing DMSO, or increasing concentrations of LW106 (IDO inhibitor), L-tryptophan, 
or indole for 48 hours. Cells were then either mock-infected, or infected with CTE3024-mCherry (10 
MOI). Cells were harvest 48 hours later and assayed by flow cytometry for mCherry expression. Bars are 
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CHAPTER 4 : CONCLUSION 
SUMMARY 
Chlamydial infection can cause severe upper reproductive tract damage in women which can 
contribute to ectopic pregnancies and infertility. Extensive research using mouse models has 
demonstrated these pathologies are driven by an overly robust host immune response to infection. 
Specifically, neutrophils are strongly associated with upper genital tract damage during chlamydial 
infection. Therefore, understanding the signals neutrophils receive in these tissues can provide targetable 
pathways to prevent extensive genital tract damage. In this dissertation, we have shown a novel role for a 
receptor expressed on neutrophils, TREM-1, in promoting damage to uterine tissue during chlamydial 
infection. We are the first to report this role during chlamydial infection, thereby expanding knowledge of 
the immune signaling pathways activated during chlamydial infection. Additionally, we have described a 
new model to study host-chlamydia interactions that is relevant to the human host. We found that primary 
FTE cells are naturally resistant to infection through high basal expression of IDO1, which starves 
chlamydia of essential tryptophan needed for growth and replication. In this Chapter, I will discuss the 
overall implications of TREM-1 during chlamydial infection and its role as a possible therapeutic target to 
reduce or prevent disease. I will also discuss the utility of a relevant human model of chlamydial infection 
to study host-pathogen interactions and signaling and how this model could be used to address questions 
relevant to human infection. Finally, I will conclude this dissertation with final remarks on how our 
discoveries contribute to the field of chlamydial pathogenesis.   
CONTRIBUTION OF A NOVEL NEUTROPHIL RECEPTOR ON UTERINE TISSUE 
PATHOLOGY DURING CHLAMYDIAL INFECTION IN THE MOUSE MODEL  
Previous studies have demonstrated the contribution of the receptor TREM-1 in other infection 




influenza A virus, LCMV, and P. aeruginosa, while leading to an increase in bacterial load and pathology 
during infection with the extracellular pathogen, K. pneumoniae (1-4). In this dissertation we report the 
role of TREM-1 in induction of upper genital tract pathology in female mice during chlamydial infection. 
Our first observation revealed female mice deficient in TREM-1 expression were able to clear chlamydial 
infection in the genital tract at a similar rate to WT mice, indicating TREM-1 plays little role in the Th1 T 
cell response, that is essential for infection resolution. Similar to studies using intracellular pathogens that 
showed reduced sequalae in the absence of TREM-1, we also saw a reduction in pathology in the uteri of 
mice during chlamydial infection. However, pathology was not reduced in the oviducts of mice, 
suggesting alternative pathways compensate for the loss of TREM-1 in the oviducts, and/or the fragile 
nature of the oviducts makes them more vulnerable to TREM-1 independent pathways of neutrophil 
activation. This explanation seems appropriate since TREM-1 deficient mice were not completely 
protected from uterine pathology, indicating a contributory role for TREM-1 as opposed to a primary role. 
In support of this, Radsak et al showed TREM-1 was sufficient to activate neutrophils alone, but 
activation was markedly increased with stimulation of TLR2, TLR3, TLR4, and TLR7/8 agonists (5). Our 
lab has previously demonstrated the importance of TLR2, and not TLR4 signaling in genital tract 
pathology during chlamydial infection (6). It would therefore be interesting to determine if targeting 
TREM-1 and TLR2 simultaneously would further decrease pathology compared to the absence of TREM-
1 or TLR2 alone, implying synergy between TREM-1 and TLR2 is responsible for neutrophil-induced 
genital tract pathology.   
A soluble form of TREM-1 (sTREM-1) has been found in serum samples of humans and mice 
during sepsis (7-9), generated from cleavage of the membrane-bound form (10). The soluble form has 
been previously shown to dampen membrane TREM-1 activation (11, 12), likely through ligand 
competition with the membrane form. Multiple studies have demonstrated the potential for sTREM-1 as a 
biomarker for sepsis (13, 14), where sTREM-1 correlated with increased mortality in septic patients (15, 




blocks membrane TREM-1, protected mice from death as a result of suppression of a systemic 
inflammatory immune response that causes shock (8, 11). These data highlight the important role TREM-
1 signaling can have on disease progression. When considered with the protective effects on pathology 
during other intracellular infections and the reduction in mouse uteri damage during chlamydial infection, 
TREM-1 appears to be a suitable target to alleviate damage associated with these pathogens. 
The signaling events and mechanisms of neutrophil transmigration across the vascular 
endothelium has been well studied and described (reviewed in (17, 18)). However, transepithelial 
migration (TeM) of neutrophils at mucosal sites during infection is less well studied. Previous studies 
have shown neutrophils initiate TeM by binding to ICAM-1 and junctional adhesion molecules (JAMs) 
on epithelial cells via CD11b/CD18 (19-25) to initiate TeM. However, the signals that direct neutrophils 
across the epithelium are controversial (reviewed in (26)). During Pseudomonas infection in trem1,3-/- 
mouse lungs, TeM was reduced (4). Similar to this study, we observed reduced TeM in the uteri of 
trem1,3-/- mice, suggesting a role for TREM-1 in the induction of TeM. Consequently, we saw reduced 
epithelial erosion and uterine pathology. We suspect the reduction in TeM leads to reduced neutrophil 
presence in the lumen, which contributes less toxic granule contents and damage to the luminal 
epithelium. Consequently, less infiltration and dead cell debris is present to promote distension of uterine 
glands. Since TREM-1 is an activation receptor, loss of TREM-1 likely reduces production of ROS that 
could assist in TeM (27) and promote damage to tissue. Nevertheless, characterizing the epithelial and/or 
chlamydial signals that promote TREM-1 neutrophil activation during chlamydial infection in the genital 
tract would greatly contribute to the understanding of TREM-1’s role in neutrophil transmigration. Our 
primary human FTE model discussed in the next section provides an excellent tool for examining the 
contribution of TREM-1 to neutrophil activation and transmigration, while simultaneously providing 




THE NEED FOR AN IN VITRO POLARIZED PRIMARY HUMAN FTE CELL MODEL TO 
STUDY CHLAMYDIAL INFECTION 
Researchers are always working to find perfect model systems to recapitulate infection and 
cellular signaling events that occur during native infections in human tissue. While many non-human 
mammalian models have advanced our understanding of pathogenic infections and the host immune 
response, some questions cannot be answered using animal models, such as those in which mouse and 
human pathways differ. These include the course, pathology, and host tropism of genital chlamydial 
infections. Mice typically clear C. muridarum infection in 3-4 weeks, while C. trachomatis infections in 
humans can last months or even longer (28-31). Furthermore, infection of the mouse genital tract with 
mouse-specific Chlamydia, C. muridarum (32, 33), leads to severe genital tract pathology in the majority 
of infected mice, likely because C. muridarum has increased replication rates and has adapted to be 
resistant to mouse IFNg signaling (34-36). Although mice are susceptible to C. trachomatis infection, 
infection causes less inflammation and chlamydiae do not ascend to the oviducts. To induce inflammation 
and long-term pathology, researchers must inoculate mice with high bacterial titers directly into the 
uterus. This is because C. trachomatis is highly sensitive to mouse IFNg-dependent killing (reviewed in 
(37). In human epithelial cells (but not mouse), IFNg induces expression of IDO, which depletes 
intracellular tryptophan. In the presence of indole, C. trachomatis can produce tryptophan using the 
enzyme tryptophan synthase to overcome tryptophan depletion. Chlamydia muridarum lacks expression 
of tryptophan synthase, and therefore cannot use indole to synthesize tryptophan, making it sensitive to 
human IFNg mediated IDO expression (38), Conversely, IFNg signaling in mouse cells does not induce 
IDO expression, but instead induces p47GTPase that can target C. trachomatis but not C. muridarum. 
There are further differences between human and mouse cells as well. In human cells, chlamydial 
proteases cause p65 degradation, thereby preventing NF-kB activation. However, mouse p65 is resistant 
to chlamydial-induced degradation (39). Further, Chlamydia infection in human cells results in 
degradation of the tumor suppressor p53, which is responsible for inducing cell-cycle arrest and apoptosis 




are more susceptible to apoptosis during infection. Together, these differences highlight the importance of 
studying host intracellular signaling pathways in appropriate human cells infected with the matched 
chlamydial strain C. trachomatis. These evolutionary selections of species-host specificity, driven by 
IFNg and other cell signaling molecules make modeling infection and disease with C. trachomatis in mice 
complicated. They also highlight the choice of model systems must be carefully considered when 
addressing biological questions. 
In this dissertation, I have described an in vitro cell culture model of human FTE cells that we 
have generated, adding to the repertoire of model systems to study Chlamydia-host interactions and the 
host responses to infection. In this model, human FTE cells were grown in an ALI, where they were 
polarized, formed cilia, and produced mucin proteins consistent with Fallopian tube explants. Despite our 
low infection rates initially, the FTE cells responded to a low-passage C. trachomatis strain isolated from 
a woman with endometrial infection. We observed establishment of inclusions, EB to RB transition, and 
RB to EB transition. We also demonstrated the ability to detect constitutive (ndk, uhpC, and secA) and 
late (glgA and hctA) expressed chlamydial genes. Therefore, this model will provide a useful tool to 
further study the chlamydial and host signals that induce chlamydial life cycle changes in a relevant cell 
type. 
The FTE cells responded to chlamydial infection by increasing production of amino acid 
transporters responsible for tryptophan and glutamine transport, SLC3A2 (41, 42) and SLC15A (43), 
respectively, demonstrating the ability of Chlamydia to alter host intracellular dynamics to support 
growth and replication. Additionally, we observed the production of the neutrophil chemoattractants 
CXCL1 (GROa) and CXCL8 (IL-8), which have been previously shown in other Chlamydia infection 
model systems (44, 45). Chlamydia infection also increased host cell surface expression of proteins 
involved in cellular attachment, IFNGR, and HLA class I and II, suggesting our cell culture model may be 
suitable for co-culture studies with HLA matched T cells. Together, our data suggest our primary human 




THE IMPACT OF IDO EXPRESSION IN PRIMARY FTE CELLS ON CHLAMYDIAL 
PATHOGENSIS 
We showed that primary human FTE cells are highly resistant to infection compared to HeLa 
cells. Despite our best efforts to increase infection by removing mucus with mucolytic agents or treatment 
with estrogen (46) and/or progesterone, we were only able to achieve a low infection rate (<10%) with 
centrifugation and using a high MOI. Therefore, we began investigating known mechanisms that prevent 
chlamydial growth in cells. The primary mechanism the immune system uses to eliminate intracellular 
chlamydiae is through IFNg signaling. Natural killer and T cells secrete IFNg that binds to IFNGR on the 
surface of infected cells (47-49), resulting in STAT1 activation. Subsequently, cells induce IDO 
expression, which catabolizes tryptophan, reducing intracellular pools that are required by Chlamydia for 
growth (50-52). We observed increased gene expression of ido1 in our FTE cell model in the absence of 
immune cells, suggesting human FTE cells have high basal ido1 expression compared to HeLa cells. In 
support of our observation, Sedlmayr et al noted high IDO1 staining in epithelial cells from Fallopian 
tube and cervical explants (53). Lower expression of IDO1 in HeLa cells may be due to lab adaptations, 
as ido1 expression was also high in epithelial cells of normal cervical explants (53). These data, combined 
with ours, could explain the low incidence of tubal complications in human infections despite the high 
prevalence of chlamydial infections in women (54-56).  
It is interesting that uninfected FTE cells expressed high levels of ido1, and that Chlamydia 
infection did not significantly increase expression. Although type II IFN signaling via IFNg is typically 
regarded as an inducer of the transcription factor STAT1, during chlamydial infection, type I and III IFN 
signaling can also activate STAT1. Previous studies have shown that chlamydial infection alone is 
sufficient to increase expression of STAT1 through type I IFN signaling (57), and could reduce 
chlamydial growth by tryptophan depletion (58). Type I IFN signaling can be initiated by IFNa, IFNb, or 
IFNe, all of which are produced by epithelial cells in the female genital tract (59, 60). IFNa and IFNb are 




significant increases in ido1 expression after infection, our results suggest that constitutive ido1 
expression is less likely due to inducible IFNb or IFNl, but a result of constitutive IFNe expression in 
these cells. Future studies should assess the contribution of IFNe and STAT1 activation in the primary 
FTE cells, as these have been previously shown to increase STAT1 activation and IDO expression, and 
therefore could explain the high basal expression of ido1 in primary FTE cells.  
Investigations of constitutive levels of ido1 expression in the upper genital tracts of women who 
develop upper genital tract sequalae from chlamydial infection, relative to women who do not, expose a 
potential use for ido1 expression as a biomarker for susceptibility. Several studies have already revealed 
the potential for products of the IDO1 pathway to serve as biomarkers for lung cancer, inflammatory 
bowel disease, and Crohn’s disease (61-63).  
FINAL REMARKS 
In this dissertation, I have described the generation of a primary human FTE model that is 
suitable to study chlamydial-host interactions with potential to expand into a co-culture system with 
immune cells to study human immune responses during infection. I have also discussed a role for IDO-
dependent tryptophan depletion that restricts chlamydial infection in these cells in the absence of immune 
cells, offering a new perspective on the previous notion that IFN signaling is required for IDO-dependent 
chlamydial growth restriction in infected cells. Further insights into the signals that promote high basal 
expression of IDO in resting primary FTE cells could expose novel signaling pathways in the female 
genital tract that discourage chlamydial infection. Lastly, I have demonstrated a role for a receptor on 
neutrophils that had not previously been considered in the context of chlamydial infections, exposing a 
potential pathway to target to reduce the sequalae caused by chlamydial infection in the female genital 
tract. The findings included in this dissertation will contribute to the chlamydial biology field by opening 
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